Thymocyte-thymic	O
epithelial	B-cell_type
cell	I-cell_type
interaction	O
leads	O
to	O
high-level	O
replication	O
of	O
human	O
immunodeficiency	O
virus	O
exclusively	O
in	O
mature	B-cell_type
CD4	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
CD8	I-cell_type
(	I-cell_type
-	I-cell_type
)	I-cell_type
CD3	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
thymocytes	I-cell_type
:	O
a	O
critical	O
role	O
for	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
and	O
interleukin-7	B-protein
.	O

This	O
work	O
aims	O
at	O
identifying	O
the	O
thymocyte	O
subpopulation	O
able	O
to	O
support	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
replication	O
under	O
the	O
biological	O
stimuli	O
of	O
the	O
thymic	O
microenvironment	O
.	O

In	O
this	O
report	O
we	O
demonstrate	O
that	O
interaction	O
with	O
thymic	B-cell_type
epithelial	I-cell_type
cells	I-cell_type
(	O
TEC	B-cell_type
)	O
induces	O
a	O
high-level	O
replication	O
of	O
the	O
T-tropic	B-protein
primary	I-protein
isolate	I-protein
HIV-1	I-protein
(	O
B-LAIp	B-protein
)	O
exclusively	O
in	O
the	O
mature	O
CD4	B-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
CD8	I-cell_type
(	I-cell_type
-	I-cell_type
)	I-cell_type
CD3	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
thymocytes	I-cell_type
.	O

Tumor	B-protein
necrosis	I-protein
factor	I-protein
(	O
TNF	B-protein
)	O
and	O
interleukin-7	B-protein
(	O
IL-7	B-protein
)	O
,	O
secreted	O
during	O
this	O
interaction	O
,	O
are	O
critical	O
cytokines	O
for	O
HIV	B-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
transactivation	O
through	O
NF-kappaB	B-protein
-dependent	O
activation	O
.	O

TNF	B-protein
is	O
the	O
major	O
inducer	O
of	O
NF-kappaB	B-protein
and	O
particularly	O
of	O
the	O
p50-p65	B-protein
complex	I-protein
,	O
whereas	O
IL-7	B-protein
acts	O
as	O
a	O
cofactor	O
by	O
sustaining	O
the	O
expression	O
of	O
the	O
p75	B-protein
TNF	I-protein
receptor	I-protein
.	O

The	O
requirement	O
for	O
TNF	B-protein
is	O
further	O
confirmed	O
by	O
the	O
observation	O
that	O
the	O
inability	O
of	O
the	O
intermediate	B-cell_type
CD4	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
CD8	I-cell_type
(	I-cell_type
-	I-cell_type
)	I-cell_type
CD3	I-cell_type
(	I-cell_type
-	I-cell_type
)	I-cell_type
thymocytes	I-cell_type
to	O
replicate	O
the	O
virus	O
is	O
associated	O
with	O
a	O
defect	O
in	O
TNF	B-protein
production	O
during	O
their	O
interaction	O
with	O
TEC	B-cell_type
and	O
correlates	O
with	O
the	O
absence	O
of	O
nuclear	O
NF-kappaB	B-protein
activity	O
in	O
these	O
freshly	B-cell_type
isolated	I-cell_type
thymocytes	I-cell_type
.	O

Addition	O
of	O
exogenous	O
TNF	B-protein
to	O
the	O
intermediate	B-cell_line
thymocyte	I-cell_line
cultures	I-cell_line
induces	O
NF-kappaB	B-protein
activity	O
and	O
is	O
sufficient	O
to	O
promote	O
HIV	O
replication	O
in	O
the	O
cocultures	O
with	O
TEC	B-cell_type
.	O

The	O
other	O
major	O
subpopulation	O
expressing	O
the	O
CD4	B-protein
receptor	I-protein
,	O
namely	O
,	O
the	O
double-positive	B-cell_type
(	I-cell_type
DP	I-cell_type
)	I-cell_type
CD4	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
CD8	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
CD3	I-cell_type
(	I-cell_type
+/-	I-cell_type
)	I-cell_type
thymocytes	I-cell_type
,	O
despite	O
the	O
entry	O
of	O
the	O
virus	O
,	O
do	O
not	O
produce	O
a	O
significant	O
level	O
of	O
virus	O
,	O
presumably	O
because	O
they	O
are	O
unresponsive	O
to	O
TNF	B-protein
and	O
IL-7	B-protein
.	O

Together	O
,	O
these	O
data	O
suggest	O
that	O
in	O
vivo	O
,	O
despite	O
an	O
efficient	O
entry	O
of	O
the	O
virus	O
in	O
all	O
the	O
CD4	B-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
subpopulations	I-cell_type
,	O
a	O
high	O
viral	O
load	O
may	O
be	O
generated	O
exclusively	O
within	O
the	O
mature	B-cell_type
CD4	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
CD8	I-cell_type
(	I-cell_type
-	I-cell_type
)	I-cell_type
CD3	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
subset	I-cell_type
of	I-cell_type
thymocytes	I-cell_type
.	O

However	O
,	O
under	O
conditions	O
of	O
inflammatory	O
response	O
after	O
infection	O
,	O
TNF	B-protein
might	O
also	O
be	O
present	O
in	O
the	O
intermediate	B-cell_type
thymocyte	I-cell_type
compartment	I-cell_type
,	O
leading	O
to	O
efficient	O
HIV	O
replication	O
in	O
these	O
cells	O
.	O

JOURNAL	NULL
or	NULL
ViRoLOGY	NULL
,	NULL
Sept.	NULL
1999	NULL
,	NULL
p.	NULL
7533-7542	NULL
0022-538	NULL
X/99/	NULL
$	NULL
04.00+0	NULL
Vol	NULL
.	NULL

73	NULL
,	NULL
No	NULL
.	NULL

9	NULL
Copyright	NULL
©	NULL
1999	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
.	NULL

All	NULL
Rights	NULL
Reserved	NULL
.	NULL

Thymocyte-Thymic	NULL
Epithelial	NULL
Cell	NULL
Interaction	NULL
Leads	NULL
to	NULL
High-Level	NULL
Replication	NULL
of	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
Exclusively	NULL
in	NULL
Mature	NULL
CD4*	NULL
CD8~	NULL
CD3~	NULL
Thymocytes	NULL
:	NULL
a	NULL
Critical	NULL
Role	NULL
for	NULL
Tumor	NULL
Necrosis	NULL
Factor	NULL
and	NULL
Interleukin-7	NULL
L.	NULL
CHENE	NULL
,	NULL
'	NULL
M.-T.	NULL
NUGEYRE	NULL
,	NULL
'	NULL
E.	NULL
GUILLEMARD__,1	NULL
N.	NULL
MOULIAN,2	NULL
F.	NULL
BARRE-SINOUSSI	NULL
,	NULL
'	NULL
AND	NULL
N	NULL
.	NULL

ISRAEL	NULL
'	NULL
!	NULL

*	NULL
Unité	NULL
de	NULL
Biologie	NULL
des	NULL
Rétrovirus	NULL
,	NULL
Institut	NULL
Pasteur	NULL
,	NULL
75724	NULL
Paris	NULL
Cedex	NULL
15	NULL
,	NULL
``	NULL
and	NULL
Laboratoire	NULL
de	NULL
Physiologie	NULL
Thymique	NULL
,	NULL
Hopital	NULL
Marie-Lannelongue	NULL
,	NULL
CNRS	NULL
ESA-8078	NULL
,	NULL
92350	NULL
Le	NULL
Plessis-Robinson	NULL
,	NULL
``	NULL
France	NULL
Received	NULL
8	NULL
March	NULL
1999/Accepted	NULL
1	NULL
June	NULL
1999	NULL
This	NULL
work	NULL
aims	NULL
at	NULL
identifying	NULL
the	NULL
thymocyte	NULL
subpopulation	NULL
able	NULL
to	NULL
support	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
replication	NULL
under	NULL
the	NULL
biological	NULL
stimuli	NULL
of	NULL
the	NULL
thymic	NULL
microenvironment	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
demonstrate	NULL
that	NULL
interaction	NULL
with	NULL
thymic	NULL
epithelial	NULL
cells	NULL
(	NULL
TEC	NULL
)	NULL
induces	NULL
a	NULL
high-level	NULL
replication	NULL
of	NULL
the	NULL
T-tropic	NULL
primary	NULL
isolate	NULL
HIV-1	NULL
;	NULL
;	NULL
;	NULL
j	NULL
,	NULL
exclusively	NULL
in	NULL
the	NULL
mature	NULL
CD4*	NULL
CD8~	NULL
CD3*	NULL
thymocytes	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
LNF	NULL
)	NULL
and	NULL
interleukin-7	NULL
(	NULL
IL-7	NULL
)	NULL
,	NULL
secreted	NULL
during	NULL
this	NULL
interaction	NULL
,	NULL
are	NULL
critical	NULL
cytokines	NULL
for	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat	NULL
transactivation	NULL
through	NULL
activation	NULL
.	NULL

TNF	NULL
is	NULL
the	NULL
major	NULL
inducer	NULL
of	NULL
NF-KB	NULL
and	NULL
particularly	NULL
of	NULL
the	NULL
p50-p65	NULL
complex	NULL
,	NULL
whereas	NULL
IL-7	NULL
acts	NULL
as	NULL
a	NULL
cofactor	NULL
by	NULL
sustaining	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
p75	NULL
TNF	NULL
receptor	NULL
.	NULL

The	NULL
requirement	NULL
for	NULL
TNF	NULL
is	NULL
further	NULL
confirmed	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
inability	NULL
of	NULL
the	NULL
intermediate	NULL
CD4*	NULL
CD8~	NULL
CD3~	NULL
thymocytes	NULL
to	NULL
replicate	NULL
the	NULL
virus	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
defect	NULL
in	NULL
TNF	NULL
production	NULL
during	NULL
their	NULL
interaction	NULL
with	NULL
TEC	NULL
and	NULL
correlates	NULL
with	NULL
the	NULL
absence	NULL
of	NULL
nuclear	NULL
NF-KB	NULL
activity	NULL
in	NULL
these	NULL
freshly	NULL
isolated	NULL
thymocytes	NULL
.	NULL

Addition	NULL
of	NULL
exogenous	NULL
TNF	NULL
to	NULL
the	NULL
intermediate	NULL
thymocyte	NULL
cultures	NULL
induces	NULL
NF-KB	NULL
activity	NULL
and	NULL
is	NULL
sufficient	NULL
to	NULL
promote	NULL
HIV	NULL
replication	NULL
in	NULL
the	NULL
cocultures	NULL
with	NULL
TEC	NULL
.	NULL

The	NULL
other	NULL
major	NULL
subpopulation	NULL
expressing	NULL
the	NULL
CD4	NULL
receptor	NULL
,	NULL
namely	NULL
,	NULL
the	NULL
double-positive	NULL
(	NULL
DP	NULL
)	NULL
CD4*	NULL
CD8	NULL
*	NULL
CD3~*	NULL
thymocytes	NULL
,	NULL
despite	NULL
the	NULL
entry	NULL
of	NULL
the	NULL
virus	NULL
,	NULL
do	NULL
not	NULL
produce	NULL
a	NULL
significant	NULL
level	NULL
of	NULL
virus	NULL
,	NULL
presumably	NULL
because	NULL
they	NULL
are	NULL
unresponsive	NULL
to	NULL
TNF	NULL
and	NULL
IL-7	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
in	NULL
vivo	NULL
,	NULL
despite	NULL
an	NULL
efficient	NULL
entry	NULL
of	NULL
the	NULL
virus	NULL
in	NULL
all	NULL
the	NULL
CD4	NULL
*	NULL
subpopulations	NULL
,	NULL
a	NULL
high	NULL
viral	NULL
load	NULL
may	NULL
be	NULL
generated	NULL
exclusively	NULL
within	NULL
the	NULL
mature	NULL
CD4*	NULL
CD87	NULL
CD3	NULL
%	NULL
*	NULL
subset	NULL
of	NULL
thymocytes	NULL
.	NULL

However	NULL
,	NULL
under	NULL
conditions	NULL
of	NULL
inflammatory	NULL
response	NULL
after	NULL
infection	NULL
,	NULL
TNF	NULL
might	NULL
also	NULL
be	NULL
present	NULL
in	NULL
the	NULL
intermediate	NULL
thymocyte	NULL
compartment	NULL
,	NULL
leading	NULL
to	NULL
efficient	NULL
HIV	NULL
replication	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

The	NULL
progression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
infection	NULL
is	NULL
clearly	NULL
associated	NULL
with	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
viral	NULL
load	NULL
in	NULL
plasma	NULL
and	NULL
a	NULL
progressive	NULL
depletion	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

One	NULL
explanation	NULL
for	NULL
this	NULL
depletion	NULL
is	NULL
the	NULL
exhaustion	NULL
of	NULL
T-cell	NULL
turn-over	NULL
,	NULL
which	NULL
must	NULL
occur	NULL
at	NULL
a	NULL
very	NULL
high	NULL
rate	NULL
to	NULL
replace	NULL
the	NULL
CD4	NULL
*	NULL
lymphocytes	NULL
permanently	NULL
destroyed	NULL
during	NULL
HIV	NULL
infection	NULL
(	NULL
15	NULL
,	NULL
23	NULL
,	NULL
59	NULL
)	NULL
.	NULL

More	NULL
recent	NULL
studies	NULL
on	NULL
the	NULL
kinetics	NULL
of	NULL
the	NULL
increase	NULL
in	NULL
the	NULL
number	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
after	NULL
triple-combination	NULL
therapies	NULL
demonstrated	NULL
that	NULL
the	NULL
mechanisms	NULL
of	NULL
T-cell	NULL
depletion	NULL
during	NULL
HIV	NULL
infection	NULL
are	NULL
more	NULL
complex	NULL
(	NULL
36	NULL
,	NULL
40	NULL
)	NULL
.	NULL

The	NULL
depletion	NULL
observed	NULL
in	NULL
the	NULL
blood	NULL
compartment	NULL
may	NULL
result	NULL
from	NULL
a	NULL
combination	NULL
of	NULL
the	NULL
trapping	NULL
of	NULL
these	NULL
cells	NULL
in	NULL
lymph	NULL
nodes	NULL
and	NULL
inflamed	NULL
tissues	NULL
(	NULL
3	NULL
,	NULL
40	NULL
)	NULL
and	NULL
a	NULL
failure	NULL
of	NULL
T-cell	NULL
regeneration	NULL
in	NULL
primary	NULL
lymphoid	NULL
organs	NULL
and	NULL
particularly	NULL
in	NULL
the	NULL
thymus	NULL
(	NULL
17	NULL
,	NULL
36	NULL
,	NULL
61	NULL
)	NULL
.	NULL

Although	NULL
T-cell	NULL
development	NULL
can	NULL
occur	NULL
via	NULL
extrathymic	NULL
path-ways	NULL
,	NULL
generation	NULL
of	NULL
the	NULL
complete	NULL
T-cell	NULL
repertoire	NULL
,	NULL
required	NULL
for	NULL
immune	NULL
system	NULL
function	NULL
,	NULL
is	NULL
dependent	NULL
upon	NULL
the	NULL
thymus	NULL
.	NULL

This	NULL
organ	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
still	NULL
functional	NULL
in	NULL
adults	NULL
,	NULL
albeit	NULL
less	NULL
actively	NULL
(	NULL
17	NULL
)	NULL
.	NULL

HIV	NULL
infection	NULL
is	NULL
accompanied	NULL
by	NULL
a	NULL
decrease	NULL
in	NULL
thymic	NULL
function	NULL
(	NULL
17	NULL
)	NULL
,	NULL
and	NULL
antiviral	NULL
therapies	NULL
contribute	NULL
to	NULL
immune	NULL
system	NULL
reconstitution	NULL
by	NULL
a	NULL
recovery	NULL
of	NULL
naive	NULL
T	NULL
cells	NULL
,	NULL
probably	NULL
through	NULL
expansion	NULL
of	NULL
preexisting	NULL
cells	NULL
and	NULL
thymic	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Unité	NULL
de	NULL
Biologie	NULL
des	NULL
Rétrovirus	NULL
,	NULL
Institut	NULL
Pasteur	NULL
,	NULL
25	NULL
rue	NULL
du	NULL
Dr	NULL
Roux	NULL
,	NULL
75724	NULL
Paris	NULL
Cedex	NULL
15	NULL
,	NULL
France	NULL
.	NULL

Phone	NULL
:	NULL
33	NULL
1	NULL
45	NULL
68	NULL
89	NULL
44/87	NULL
33	NULL
.	NULL

Fax	NULL
:	NULL
33	NULL
1	NULL
45	NULL
68	NULL
89	NULL
57	NULL
.	NULL

E-mail	NULL
:	NULL
nisrael	NULL
@	NULL
pasteur.fr	NULL
.	NULL

7533	NULL
production	NULL
of	NULL
new	NULL
cells	NULL
(	NULL
3	NULL
,	NULL
37	NULL
,	NULL
61	NULL
,	NULL
65	NULL
)	NULL
.	NULL

However	NULL
,	NULL
this	NULL
renewal	NULL
occurs	NULL
slowly	NULL
(	NULL
40	NULL
)	NULL
,	NULL
suggesting	NULL
,	NULL
in	NULL
some	NULL
cases	NULL
,	NULL
a	NULL
severe	NULL
impairment	NULL
of	NULL
T-cell	NULL
progenitors	NULL
,	NULL
probably	NULL
depending	NULL
on	NULL
the	NULL
stage	NULL
of	NULL
the	NULL
disease	NULL
and	NULL
the	NULL
age	NULL
of	NULL
the	NULL
patient	NULL
.	NULL

Indeed	NULL
,	NULL
observations	NULL
of	NULL
thymuses	NULL
from	NULL
HIV-infected	NULL
pediatric	NULL
patients	NULL
,	NULL
who	NULL
underwent	NULL
a	NULL
rapid	NULL
progression	NULL
to	NULL
AIDS	NULL
,	NULL
led	NULL
to	NULL
the	NULL
conclusion	NULL
that	NULL
insult	NULL
to	NULL
this	NULL
organ	NULL
induces	NULL
a	NULL
severe	NULL
thymocyte	NULL
depletion	NULL
associated	NULL
with	NULL
a	NULL
profound	NULL
disorganization	NULL
of	NULL
the	NULL
epithelial	NULL
network	NULL
(	NULL
27	NULL
,	NULL
41	NULL
,	NULL
44	NULL
)	NULL
.	NULL

Modification	NULL
of	NULL
the	NULL
structure	NULL
of	NULL
the	NULL
thymus	NULL
and	NULL
loss	NULL
of	NULL
thymocytes	NULL
were	NULL
also	NULL
found	NULL
in	NULL
thymic	NULL
tissues	NULL
from	NULL
infected	NULL
macaques	NULL
(	NULL
39	NULL
)	NULL
and	NULL
from	NULL
SCID-hu	NULL
mice	NULL
(	NULL
2	NULL
,	NULL
48	NULL
)	NULL
.	NULL

This	NULL
profound	NULL
deterioration	NULL
was	NULL
also	NULL
confirmed	NULL
by	NULL
the	NULL
inability	NULL
to	NULL
completely	NULL
restore	NULL
thymopoiesis	NULL
in	NULL
infected	NULL
thymuses	NULL
from	NULL
SCID-hu	NULL
mice	NULL
treated	NULL
with	NULL
highly	NULL
active	NULL
antiretroviral	NULL
therapy	NULL
(	NULL
61	NULL
)	NULL
.	NULL

For	NULL
a	NULL
better	NULL
understanding	NULL
of	NULL
the	NULL
immunopathogenesis	NULL
associated	NULL
with	NULL
HIV	NULL
infection	NULL
of	NULL
the	NULL
thymus	NULL
,	NULL
we	NULL
previously	NULL
examined	NULL
the	NULL
factors	NULL
and	NULL
mechanisms	NULL
controlling	NULL
HIV	NULL
replication	NULL
in	NULL
this	NULL
organ	NULL
(	NULL
14	NULL
,	NULL
45	NULL
)	NULL
.	NULL

The	NULL
goal	NULL
of	NULL
the	NULL
present	NULL
work	NULL
was	NULL
the	NULL
identification	NULL
of	NULL
thymocyte	NULL
subpopulations	NULL
that	NULL
allow	NULL
efficient	NULL
HIV	NULL
replication	NULL
in	NULL
the	NULL
thymic	NULL
environment	NULL
.	NULL

This	NULL
relates	NULL
to	NULL
the	NULL
general	NULL
question	NULL
of	NULL
the	NULL
control	NULL
of	NULL
spreading	NULL
of	NULL
the	NULL
virus	NULL
in	NULL
this	NULL
organ	NULL
and	NULL
its	NULL
consequences	NULL
for	NULL
the	NULL
peripheral	NULL
viral	NULL
load	NULL
and	NULL
thymopoiesis	NULL
.	NULL

Using	NULL
an	NULL
autologous	NULL
mixed	NULL
culture	NULL
with	NULL
thymic	NULL
epithelial	NULL
cells	NULL
(	NULL
TEC	NULL
)	NULL
and	NULL
the	NULL
total	NULL
population	NULL
of	NULL
thymocytes	NULL
,	NULL
we	NULL
previously	NULL
demonstrated	NULL
that	NULL
interaction	NULL
of	NULL
infected	NULL
thymocytes	NULL
with	NULL
TEC	NULL
is	NULL
a	NULL
prerequisite	NULL
for	NULL
high-level	NULL
HIV	NULL
replication	NULL
(	NULL
45	NULL
)	NULL
.	NULL

7534	NULL
CHENE	NULL
ET	NULL
AL	NULL
.	NULL

Cytokines	NULL
secreted	NULL
during	NULL
this	NULL
TEC-thymocyte	NULL
interaction	NULL
were	NULL
first	NULL
identified	NULL
as	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
,	NULL
interleu-kin-1	NULL
(	NULL
IL-1	NULL
)	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
,	NULL
and	NULL
a	NULL
role	NULL
for	NULL
IL-7	NULL
was	NULL
demonstrated	NULL
later	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
provided	NULL
evidence	NULL
that	NULL
NF-kB	NULL
activation	NULL
is	NULL
required	NULL
for	NULL
a	NULL
high-level	NULL
replication	NULL
of	NULL
HIV	NULL
in	NULL
thymocytes	NULL
(	NULL
14	NULL
)	NULL
by	NULL
demonstrating	NULL
that	NULL
HIV	NULL
provirus	NULL
with	NULL
its	NULL
two	NULL
kB	NULL
sites	NULL
deleted	NULL
fails	NULL
to	NULL
replicate	NULL
in	NULL
thymocytes	NULL
cocultured	NULL
with	NULL
TEC	NULL
.	NULL

NF-KB	NULL
is	NULL
composed	NULL
of	NULL
homo-	NULL
and	NULL
heterodimers	NULL
of	NULL
members	NULL
of	NULL
the	NULL
Rel/NF-B	NULL
family	NULL
(	NULL
p65	NULL
,	NULL
c-Rel	NULL
,	NULL
Rel	NULL
B	NULL
,	NULL
p50	NULL
and	NULL
its	NULL
precursor	NULL
p105	NULL
,	NULL
and	NULL
p52	NULL
and	NULL
its	NULL
precursor	NULL
p100	NULL
)	NULL
(	NULL
5	NULL
,	NULL
35	NULL
)	NULL
.	NULL

These	NULL
dimers	NULL
are	NULL
sequestered	NULL
in	NULL
the	NULL
cytosol	NULL
of	NULL
unstimulated	NULL
cells	NULL
via	NULL
interactions	NULL
with	NULL
a	NULL
family	NULL
of	NULL
inhibitory	NULL
proteins	NULL
called	NULL
IxBs	NULL
(	NULL
IxBa	NULL
«	NULL
,	NULL
IxBB	NULL
,	NULL
and	NULL
IxBg	NULL
)	NULL
(	NULL
60	NULL
)	NULL
.	NULL

Following	NULL
activation	NULL
by	NULL
various	NULL
immune	NULL
and	NULL
inflammatory	NULL
stimuli	NULL
,	NULL
IxB	NULL
molecules	NULL
are	NULL
degraded	NULL
through	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
,	NULL
allowing	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
activation	NULL
of	NULL
its	NULL
target	NULL
genes	NULL
(	NULL
32	NULL
,	NULL
35	NULL
)	NULL
.	NULL

We	NULL
previously	NULL
demonstrated	NULL
,	NULL
using	NULL
the	NULL
total	NULL
population	NULL
of	NULL
thymocytes	NULL
,	NULL
that	NULL
TNF	NULL
in	NULL
association	NULL
with	NULL
IL-7	NULL
induced	NULL
the	NULL
p50-p65	NULL
activity	NULL
observed	NULL
in	NULL
the	NULL
nuclear	NULL
extracts	NULL
of	NULL
these	NULL
cells	NULL
.	NULL

The	NULL
data	NULL
obtained	NULL
in	NULL
our	NULL
coculture	NULL
system	NULL
with	NULL
TEC	NULL
and	NULL
the	NULL
total	NULL
population	NULL
of	NULL
thymocytes	NULL
did	NULL
not	NULL
indicate	NULL
,	NULL
however	NULL
,	NULL
whether	NULL
all	NULL
the	NULL
subpopulations	NULL
expressing	NULL
the	NULL
CD4	NULL
receptor	NULL
were	NULL
able	NULL
to	NULL
produce	NULL
virus	NULL
at	NULL
a	NULL
high	NULL
level	NULL
in	NULL
this	NULL
partially	NULL
reconstituted	NULL
thymic	NULL
environment	NULL
.	NULL

This	NULL
is	NULL
an	NULL
important	NULL
question	NULL
in	NULL
view	NULL
of	NULL
the	NULL
conflicting	NULL
data	NULL
found	NULL
in	NULL
the	NULL
literature	NULL
.	NULL

A	NULL
number	NULL
of	NULL
in	NULL
vitro	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
all	NULL
the	NULL
human	NULL
CD4	NULL
*	NULL
thymocytes	NULL
are	NULL
susceptible	NULL
to	NULL
infection	NULL
(	NULL
16	NULL
,	NULL
20	NULL
,	NULL
52	NULL
,	NULL
55	NULL
,	NULL
56	NULL
)	NULL
.	NULL

Controversial	NULL
in	NULL
vivo	NULL
studies	NULL
report	NULL
a	NULL
specific	NULL
infection	NULL
of	NULL
mature	NULL
(	NULL
41	NULL
)	NULL
or	NULL
immature	NULL
(	NULL
44	NULL
)	NULL
thymocytes	NULL
within	NULL
the	NULL
thymuses	NULL
from	NULL
infected	NULL
infants	NULL
.	NULL

In	NULL
thymuses	NULL
from	NULL
macaques	NULL
infected	NULL
with	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
,	NULL
particles	NULL
were	NULL
detected	NULL
either	NULL
in	NULL
the	NULL
cortical	NULL
area	NULL
(	NULL
7	NULL
)	NULL
or	NULL
mainly	NULL
in	NULL
the	NULL
medullary	NULL
area	NULL
(	NULL
63	NULL
)	NULL
.	NULL

In	NULL
the	NULL
SCID-hu	NULL
mouse	NULL
model	NULL
,	NULL
viral	NULL
DNA	NULL
sequences	NULL
were	NULL
detected	NULL
by	NULL
PCR	NULL
analysis	NULL
in	NULL
all	NULL
the	NULL
thymocytes	NULL
expressing	NULL
the	NULL
CD4	NULL
receptor	NULL
(	NULL
30	NULL
,	NULL
49	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
kinetics	NULL
of	NULL
replication	NULL
in	NULL
the	NULL
different	NULL
subpopulations	NULL
was	NULL
shown	NULL
to	NULL
vary	NULL
according	NULL
to	NULL
the	NULL
viral	NULL
isolates	NULL
(	NULL
10	NULL
,	NULL
49	NULL
)	NULL
,	NULL
and	NULL
this	NULL
is	NULL
very	NULL
probably	NULL
related	NULL
to	NULL
the	NULL
distribution	NULL
of	NULL
the	NULL
chemokine	NULL
receptors	NULL
on	NULL
the	NULL
human	NULL
thymocyte	NULL
subsets	NULL
and	NULL
to	NULL
their	NULL
usage	NULL
by	NULL
the	NULL
viral	NULL
isolates	NULL
(	NULL
9	NULL
,	NULL
31	NULL
,	NULL
42	NULL
,	NULL
64	NULL
)	NULL
.	NULL

However	NULL
,	NULL
an	NULL
efficient	NULL
entry	NULL
of	NULL
the	NULL
virus	NULL
does	NULL
not	NULL
necessarily	NULL
lead	NULL
to	NULL
a	NULL
productive	NULL
infection	NULL
.	NULL

We	NULL
used	NULL
the	NULL
T-tropic	NULL
primary	NULL
isolate	NULL
HIV-1	NULL
»	NULL
;	NULL
/j	NULL
,	NULL
which	NULL
is	NULL
able	NULL
to	NULL
enter	NULL
all	NULL
the	NULL
CD4	NULL
*	NULL
subpopulations	NULL
of	NULL
thymocytes	NULL
(	NULL
since	NULL
this	NULL
isolate	NULL
preferentially	NULL
uses	NULL
the	NULL
CXCR4	NULL
coreceptor	NULL
)	NULL
,	NULL
to	NULL
test	NULL
its	NULL
capacity	NULL
to	NULL
replicate	NULL
in	NULL
these	NULL
distinct	NULL
subpopulations	NULL
.	NULL

We	NULL
showed	NULL
that	NULL
the	NULL
mature	NULL
CD4*	NULL
CD8~	NULL
CD3¢	NULL
subpopulation	NULL
is	NULL
the	NULL
only	NULL
one	NULL
able	NULL
to	NULL
sustain	NULL
a	NULL
high	NULL
level	NULL
of	NULL
HIV	NULL
replication	NULL
when	NULL
cocultured	NULL
with	NULL
TEC	NULL
.	NULL

TNF	NULL
and	NULL
IL-7	NULL
were	NULL
confirmed	NULL
to	NULL
be	NULL
the	NULL
major	NULL
coinducers	NULL
of	NULL
replication	NULL
in	NULL
these	NULL
cells	NULL
through	NULL
induction	NULL
of	NULL
the	NULL
p50-p65	NULL
complex	NULL
of	NULL
NF-	NULL
«	NULL
xB	NULL
.	NULL

We	NULL
also	NULL
provide	NULL
evidence	NULL
that	NULL
IL-7	NULL
mediates	NULL
TNF-induced	NULL
NF-kB	NULL
activation	NULL
by	NULL
sustaining	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
p75	NULL
TNF	NULL
receptor	NULL
.	NULL

The	NULL
other	NULL
CD4	NULL
*	NULL
subpopulations	NULL
do	NULL
not	NULL
produce	NULL
significant	NULL
amounts	NULL
of	NULL
the	NULL
virus	NULL
during	NULL
their	NULL
coculture	NULL
with	NULL
TEC	NULL
either	NULL
because	NULL
of	NULL
their	NULL
unresponsiveness	NULL
to	NULL
the	NULL
cytokines	NULL
(	NULL
double	NULL
positive	NULL
)	NULL
or	NULL
because	NULL
of	NULL
the	NULL
defect	NULL
of	NULL
TNF	NULL
production	NULL
(	NULL
inter-mediate	NULL
[	NULL
33	NULL
]	NULL
)	NULL
during	NULL
their	NULL
interaction	NULL
with	NULL
TEC	NULL
.	NULL

GM-CSF	NULL
,	NULL
mainly	NULL
secreted	NULL
by	NULL
TEC	NULL
,	NULL
strongly	NULL
amplifies	NULL
HIV	NULL
replication	NULL
in	NULL
the	NULL
intermediate	NULL
subset	NULL
but	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
mature	NULL
subset	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents	NULL
.	NULL

(	NULL
i	NULL
)	NULL
Antibodies	NULL
used	NULL
for	NULL
selection	NULL
.	NULL

To	NULL
enrich	NULL
the	NULL
different	NULL
thymic	NULL
subpopulations	NULL
by	NULL
negative	NULL
selection	NULL
,	NULL
the	NULL
following	NULL
monoclonal	NULL
antibodies	NULL
were	NULL
J.	NULL
Virou	NULL
.	NULL

used	NULL
:	NULL
CD3	NULL
(	NULL
x35	NULL
)	NULL
,	NULL
CD8	NULL
(	NULL
B9.11	NULL
)	NULL
,	NULL
CD83	NULL
(	NULL
HB15A	NULL
)	NULL
,	NULL
CD10	NULL
(	NULL
ALB	NULL
1	NULL
)	NULL
,	NULL
and	NULL
CD34	NULL
(	NULL
QBEND	NULL
10	NULL
)	NULL
(	NULL
Immunotech	NULL
,	NULL
Marseille	NULL
,	NULL
France	NULL
)	NULL
;	NULL
OKT4A	NULL
(	NULL
Ortho	NULL
Diagnostic	NULL
Systems	NULL
Inc.	NULL
,	NULL
Raritan	NULL
,	NULL
N.J.	NULL
)	NULL
;	NULL
and	NULL
CD14	NULL
(	NULL
M	NULL
@	NULL
P9	NULL
)	NULL
(	NULL
Becton	NULL
Dickinson	NULL
&	NULL
Co.	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

CD4-PE	NULL
(	NULL
1388.2	NULL
)	NULL
and	NULL
CD8-FITC	NULL
(	NULL
B9.11	NULL
)	NULL
were	NULL
used	NULL
for	NULL
positive	NULL
selection	NULL
of	NULL
the	NULL
DP	NULL
thymocytes	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
Antibodies	NULL
used	NULL
for	NULL
immunostaining	NULL
.	NULL

To	NULL
characterize	NULL
thymic	NULL
subpopulations	NULL
and	NULL
TEC	NULL
,	NULL
monoclonal	NULL
antibodies	NULL
conjugated	NULL
with	NULL
the	NULL
fluorescent	NULL
dyes	NULL
CD3-ECD	NULL
(	NULL
Coulter	NULL
Corp.	NULL
,	NULL
Hialeah	NULL
,	NULL
Fla.	NULL
)	NULL
or	NULL
CD3-fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
,	NULL
CD4-phycoerythrin	NULL
7	NULL
(	NULL
PE	NULL
)	NULL
(	NULL
13B8.2	NULL
)	NULL
,	NULL
CD8-FITC	NULL
(	NULL
B9.11	NULL
)	NULL
,	NULL
CD83-PE	NULL
(	NULL
HB15a	NULL
)	NULL
(	NULL
Immunotech	NULL
)	NULL
,	NULL
and	NULL
CD14-FITC	NULL
(	NULL
RMOS2	NULL
)	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
were	NULL
used	NULL
,	NULL
and	NULL
for	NULL
indirect	NULL
staining	NULL
,	NULL
CD7	NULL
(	NULL
8H8.1	NULL
)	NULL
,	NULL
CD10	NULL
(	NULL
ALB	NULL
1	NULL
)	NULL
,	NULL
CD34	NULL
(	NULL
QBEND	NULL
10	NULL
)	NULL
,	NULL
Cytokeratin	NULL
(	NULL
KL1	NULL
)	NULL
(	NULL
Immunotech	NULL
)	NULL
,	NULL
and	NULL
Vimentin	NULL
(	NULL
vim3B4	NULL
)	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Meylan	NULL
,	NULL
France	NULL
)	NULL
were	NULL
revealed	NULL
with	NULL
goat	NULL
anti-mouse	NULL
immunoglob-ulin	NULL
G	NULL
(	NULL
IgG	NULL
)	NULL
(	NULL
H+L	NULL
)	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
-FITC	NULL
(	NULL
Immunotech	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
two	NULL
TNF	NULL
receptors	NULL
,	NULL
p55	NULL
and	NULL
p75	NULL
,	NULL
were	NULL
determined	NULL
on	NULL
CD4*	NULL
mature	NULL
and	NULL
intermediate	NULL
thymocytes	NULL
by	NULL
using	NULL
TNF-receptor	NULL
I	NULL
(	NULL
RI	NULL
)	NULL
-FITC	NULL
(	NULL
p55	NULL
)	NULL
(	NULL
16803.1	NULL
)	NULL
and	NULL
TNF-RII-FITC	NULL
(	NULL
p75	NULL
)	NULL
(	NULL
22235.3	NULL
)	NULL
antibodies	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
)	NULL
.	NULL

Negative	NULL
controls	NULL
for	NULL
these	NULL
immunostaining	NULL
reactions	NULL
were	NULL
performed	NULL
with	NULL
mouse	NULL
IgG1	NULL
(	NULL
MARK1	NULL
)	NULL
and	NULL
IgG2a	NULL
(	NULL
U7.27	NULL
)	NULL
antibodies	NULL
.	NULL

Conjugated	NULL
mouse	NULL
IgG1-PE	NULL
(	NULL
679.1	NULL
IgG1-FITC	NULL
(	NULL
679.1Mc7	NULL
)	NULL
,	NULL
goat	NULL
anti-rabbit-FITC	NULL
,	NULL
and	NULL
goat	NULL
anti-mouse-FITC	NULL
antibodies	NULL
were	NULL
purchased	NULL
from	NULL
Immunotech	NULL
,	NULL
and	NULL
IgG1-ECD	NULL
was	NULL
from	NULL
Coulter	NULL
Corp	NULL
.	NULL

Direct	NULL
and	NULL
indirect	NULL
immunostaining	NULL
was	NULL
analyzed	NULL
by	NULL
cytofluorometry	NULL
with	NULL
an	NULL
EPICS	NULL
Profile	NULL
II	NULL
fluorometer	NULL
(	NULL
Coulter	NULL
Corp.	NULL
)	NULL
.	NULL

(	NULL
iii	NULL
)	NULL
Cytokines	NULL
.	NULL

Human	NULL
recombinant	NULL
cytokines	NULL
GM-CSF	NULL
,	NULL
IL-18	NULL
,	NULL
and	NULL
TNF	NULL
were	NULL
purchased	NULL
from	NULL
Genzyme	NULL
Corp.	NULL
(	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

;	NULL
IL-6	NULL
and	NULL
IL-7	NULL
were	NULL
purchased	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
(	NULL
Minneapolis	NULL
,	NULL
Minn.	NULL
)	NULL
.	NULL

Cytokines	NULL
were	NULL
used	NULL
at	NULL
the	NULL
following	NULL
concentrations	NULL
:	NULL
IL-6	NULL
,	NULL
10	NULL
ng/ml	NULL
;	NULL
TNF-a	NULL
,	NULL
10	NULL
ng/ml	NULL
;	NULL
IL-1B	NULL
,	NULL
10	NULL
ng/ml	NULL
;	NULL
IL-7	NULL
,	NULL
0.5	NULL
ng/ml	NULL
;	NULL
and	NULL
GM-CSF	NULL
,	NULL
20	NULL
ng/ml	NULL
.	NULL

Cell	NULL
culture	NULL
conditions	NULL
.	NULL

(	NULL
i	NULL
)	NULL
Preparation	NULL
of	NULL
TEC	NULL
.	NULL

Thymic	NULL
fragments	NULL
were	NULL
obtained	NULL
from	NULL
HIV-1-seronegative	NULL
children	NULL
(	NULL
aged	NULL
6	NULL
days	NULL
to	NULL
2	NULL
years	NULL
)	NULL
undergoing	NULL
elective	NULL
cardiac	NULL
surgery	NULL
.	NULL

TEC	NULL
were	NULL
obtained	NULL
by	NULL
the	NULL
procedure	NULL
of	NULL
Rothe	NULL
et	NULL
al	NULL
.	NULL

(	NULL
45	NULL
)	NULL
.	NULL

The	NULL
dispersed	NULL
TEC	NULL
were	NULL
seeded	NULL
in	NULL
a	NULL
selective	NULL
medium	NULL
:	NULL
McCoy	NULL
's	NULL
5A	NULL
(	NULL
GIBCO	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
1-glutamine	NULL
,	NULL
50	NULL
pg	NULL
of	NULL
penicillin-streptomycin	NULL
per	NULL
ml	NULL
,	NULL
100	NULL
pg	NULL
of	NULL
neomycin	NULL
per	NULL
ml	NULL
,	NULL
5	NULL
x	NULL
10~*	NULL
M	NULL
B-mer-captocthanol	NULL
,	NULL
20	NULL
ng	NULL
of	NULL
epidermal	NULL
growth	NULL
factor	NULL
(	NULL
Sigma	NULL
)	NULL
per	NULL
ml	NULL
,	NULL
500	NULL
ng	NULL
of	NULL
hydrocortisone	NULL
(	NULL
Sigma	NULL
)	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
5	NULL
x	NULL
10~°	NULL
M	NULL
cholera	NULL
toxin	NULL
(	NULL
Interchim	NULL
,	NULL
Montlugon	NULL
,	NULL
France	NULL
)	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Prior	NULL
to	NULL
the	NULL
coculture	NULL
,	NULL
TEC	NULL
were	NULL
maintained	NULL
in	NULL
the	NULL
selective	NULL
medium	NULL
described	NULL
above	NULL
.	NULL

An	NULL
antikeratin	NULL
antibody	NULL
stained	NULL
more	NULL
than	NULL
95	NULL
%	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
TEC-enriched	NULL
population	NULL
,	NULL
confirming	NULL
their	NULL
epithelial	NULL
characteristics	NULL
(	NULL
45	NULL
)	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
Preparation	NULL
of	NULL
thymocyte	NULL
subpopulations	NULL
.	NULL

Preparation	NULL
of	NULL
the	NULL
total	NULL
population	NULL
of	NULL
thymocytes	NULL
has	NULL
already	NULL
been	NULL
described	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Except	NULL
for	NULL
the	NULL
DP	NULL
,	NULL
most	NULL
of	NULL
the	NULL
CD4-expressing	NULL
subpopulations	NULL
were	NULL
obtained	NULL
by	NULL
negative	NULL
selection	NULL
.	NULL

Mature	NULL
CD4*	NULL
CD8~	NULL
CD3*	NULL
thymocytes	NULL
were	NULL
obtained	NULL
after	NULL
three	NULL
depletion	NULL
cycles	NULL
with	NULL
anti-CD8	NULL
,	NULL
anti-CD10	NULL
,	NULL
and	NULL
anti-CD34	NULL
antibodies	NULL
and	NULL
anti-mouse	NULL
IgG-coated	NULL
magnetic	NULL
beads	NULL
(	NULL
Immunotech	NULL
)	NULL
.	NULL

Immature	NULL
CD4*	NULL
CD8~	NULL
CD3~	NULL
thymocytes	NULL
were	NULL
obtained	NULL
after	NULL
three	NULL
depletion	NULL
cycles	NULL
with	NULL
anti-CD3	NULL
and	NULL
anti-CD8	NULL
,	NULL
anti-CD14	NULL
,	NULL
and	NULL
anti-CD83	NULL
antibodies	NULL
followed	NULL
by	NULL
anti-mouse	NULL
IgG-coated	NULL
magnetic	NULL
beads	NULL
.	NULL

Anti-CD83	NULL
was	NULL
used	NULL
to	NULL
remove	NULL
dendritic	NULL
cells	NULL
.	NULL

DP	NULL
thymocytes	NULL
were	NULL
enriched	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorting	NULL
with	NULL
CD4	NULL
and	NULL
CD8	NULL
antibodies	NULL
in	NULL
an	NULL
Elite	NULL
(	NULL
Coulter	NULL
)	NULL
cell	NULL
sorter	NULL
.	NULL

The	NULL
antibodies	NULL
that	NULL
we	NULL
used	NULL
in	NULL
this	NULL
positive	NULL
selection	NULL
did	NULL
not	NULL
induce	NULL
activation	NULL
,	NULL
since	NULL
no	NULL
replication	NULL
after	NULL
cell	NULL
activation	NULL
was	NULL
detectable	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
each	NULL
subpopulation	NULL
obtained	NULL
by	NULL
negative	NULL
selection	NULL
was	NULL
further	NULL
purified	NULL
by	NULL
depleting	NULL
monocyte/macrophage	NULL
and	NULL
dendritic	NULL
cells	NULL
with	NULL
CD14	NULL
and	NULL
CD83	NULL
antibodies	NULL
and	NULL
anti-mouse	NULL
IgG-coated	NULL
magnetic	NULL
beads	NULL
(	NULL
Immunotech	NULL
)	NULL
.	NULL

(	NULL
iii	NULL
)	NULL
Mixed-culture	NULL
procedure	NULL
.	NULL

Autologous	NULL
coculture	NULL
between	NULL
TEC	NULL
and	NULL
infected	NULL
thymocytes	NULL
,	NULL
either	NULL
the	NULL
total	NULL
population	NULL
or	NULL
each	NULL
of	NULL
the	NULL
enriched	NULL
CD4*	NULL
subpopulations	NULL
,	NULL
was	NULL
performed	NULL
3	NULL
days	NULL
after	NULL
thymus	NULL
excision	NULL
.	NULL

A	NULL
ratio	NULL
of	NULL
4	NULL
X	NULL
10°	NULL
thymocytes/5	NULL
X	NULL
10°	NULL
TEC	NULL
in	NULL
1	NULL
ml/well	NULL
(	NULL
24	NULL
wells/plate	NULL
)	NULL
was	NULL
used	NULL
in	NULL
all	NULL
the	NULL
exper-iments	NULL
.	NULL

The	NULL
coculture	NULL
medium	NULL
was	NULL
McCoy	NULL
's	NULL
5A	NULL
(	NULL
GIBCO	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
r-glutamine	NULL
,	NULL
50	NULL
g	NULL
of	NULL
penicillin-streptomycin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
100	NULL
g	NULL
of	NULL
neomycin	NULL
per	NULL
ml	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
cytokines	NULL
were	NULL
added	NULL
at	NULL
the	NULL
start	NULL
of	NULL
the	NULL
coculture	NULL
.	NULL

Infection	NULL
of	NULL
thymocytes	NULL
with	NULL
y	NULL
a	NULL
,	NULL
.	NULL

All	NULL
infections	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
primary	NULL
isolate	NULL
HIV-1p	NULL
;	NULL
aj	NULL
,	NULL
(	NULL
p	NULL
is	NULL
for	NULL
primary	NULL
isolate	NULL
)	NULL
(	NULL
6	NULL
)	NULL
.	NULL

A	NULL
total	NULL
of	NULL
4	NULL
x	NULL
10°	NULL
(	NULL
for	NULL
most	NULL
experiments	NULL
)	NULL
or	NULL
2	NULL
X	NULL
10°	NULL
(	NULL
for	NULL
the	NULL
experiment	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
thymocytes	NULL
were	NULL
infected	NULL
at	NULL
a	NULL
multiplicity	NULL
of	NULL
infection	NULL
of	NULL
about	NULL
0.001	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
thymocytes	NULL
were	NULL
then	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
RPMI	NULL
1640	NULL
containing	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
resuspended	NULL
in	NULL
culture	NULL
medium	NULL
,	NULL
and	NULL
cultured	NULL
alone	NULL
or	NULL
with	NULL
TEC	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
cytokines	NULL
.	NULL

HIV-1	NULL
p24	NULL
antigen	NULL
concentration	NULL
was	NULL
determined	NULL
in	NULL
culture	NULL
supernatants	NULL
by	NULL
using	NULL
a	NULL
p24°	NULL
``	NULL
®	NULL
antigen	NULL
detection	NULL
kit	NULL
(	NULL
Coulter	NULL
HIV-1	NULL
p24	NULL
antigen	NULL
assay	NULL
)	NULL
as	NULL
specified	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

Total-cell	NULL
extracts	NULL
were	NULL
obtained	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
thymocytes	NULL
under	NULL
different	NULL
culture	NULL
conditions	NULL
were	NULL
harvested	NULL
and	NULL
washed	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
lysed	NULL
with	NULL
30	NULL
pl	NULL
of	NULL
lysis	NULL
buffer	NULL
for	NULL
15	NULL
min	NULL
,	NULL
and	NULL
then	NULL
centrifuged	NULL
at	NULL
13,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
in	NULL
the	NULL
cell	NULL
lysate	NULL
was	NULL
determined	NULL
by	NULL
using	NULL
the	NULL
Bradford	NULL
reagent	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
,	NULL
Ivry	NULL
sur	NULL
Seine	NULL
,	NULL
France	NULL
)	NULL
.	NULL

For	NULL
the	NULL
band	NULL
shift	NULL
assay	NULL
,	NULL
the	NULL
binding-reaction	NULL
mixture	NULL
was	NULL
prepared	NULL
by	NULL
adding	NULL
,	NULL
in	NULL
the	NULL
following	NULL
order	NULL
,	NULL
the	NULL
binding	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
2	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
60	NULL
mM	NULL
KCI	NULL
,	NULL
0.01	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
0.1	NULL
mg	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
4	NULL
%	NULL
Ficoll	NULL
)	NULL
,	NULL
voL	NULL
.	NULL

73	NULL
,	NULL
1999	NULL
A	NULL
:	NULL
total	NULL
thymocytes	NULL
B	NULL
:	NULL
Immature	NULL
thymocytes	NULL
HIV	NULL
REPLICATION	NULL
IN	NULL
CD4*	NULL
THYMOCYTES	NULL
-	NULL
7535	NULL
C	NULL
:	NULL
Double	NULL
positive	NULL
thymocytes	NULL
D	NULL
:	NULL
Mature	NULL
thymocytes	NULL
TN	NULL
:	NULL
CD4	NULL
CD8CDF	NULL
CD4*CD8*CD3	NULL
``	NULL
*	NULL
CD4	NULL
**~*CD8CD3+	NULL
Intermediate	NULL
:	NULL
CD4	NULL
+	NULL
CD8	NULL
CD3	NULL
©	NULL
&	NULL
§	NULL
s	NULL
|	NULL
~	NULL
80	NULL
%	NULL
0,1	NULL
%	NULL
E	NULL
1,0	NULL
%	NULL
94,7	NULL
%	NULL
04	NULL
%	NULL
t	NULL
A	NULL
3	NULL
C	NULL
7	NULL
.	NULL

44	NULL
%	NULL
0,1	NULL
%	NULL
112	NULL
%	NULL
3,1	NULL
%	NULL
0,1	NULL
%	NULL
~	NULL
m	NULL
A	NULL
Trim®	NULL
``	NULL
minim-i	NULL
!	NULL

3.51mi	NULL
Trm	NULL
1000	NULL
1	NULL
1000	NULL
A	NULL
1000	NULL
1000	NULL
jm	NULL
CDS	NULL
&	NULL
®	NULL
®	NULL
#	NULL
1	NULL
3,5	NULL
%	NULL
55	NULL
%	NULL
d	NULL
94	NULL
%	NULL
3	NULL
-I	NULL
5	NULL
W	NULL
m	NULL
*	NULL
&	NULL
:	NULL
kﬁi	NULL
®	NULL
rand	NULL
>	NULL
1	NULL
1000	NULL
1	NULL
1900	NULL
i	NULL
1000	NULL
1	NULL
1000	NULL
J	NULL
»	NULL
CD3	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
CD4*	NULL
thymic	NULL
subpopulations	NULL
according	NULL
to	NULL
their	NULL
expression	NULL
of	NULL
CD4	NULL
,	NULL
CD8	NULL
,	NULL
and	NULL
CD3	NULL
.	NULL

Freshly	NULL
isolated	NULL
total	NULL
thymocytes	NULL
(	NULL
A	NULL
)	NULL
as	NULL
well	NULL
as	NULL
immature	NULL
(	NULL
TN	NULL
[	NULL
CD4~	NULL
CD87	NULL
CD3~	NULL
]	NULL
and	NULL
intermediate	NULL
[	NULL
CD4*	NULL
CD87	NULL
CD3~	NULL
]	NULL
)	NULL
(	NULL
B	NULL
)	NULL
,	NULL
double-positive	NULL
CD4*	NULL
CD8	NULL
``	NULL
CD3	NULL
``	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
mature	NULL
CD4*	NULL
CD8~	NULL
CD3*	NULL
(	NULL
D	NULL
)	NULL
thymocytes	NULL
were	NULL
characterized	NULL
to	NULL
demonstrate	NULL
purity	NULL
.	NULL

These	NULL
various	NULL
populations	NULL
were	NULL
immunophenotyped	NULL
for	NULL
CD4	NULL
(	NULL
PE	NULL
)	NULL
and	NULL
CD8	NULL
(	NULL
FITC	NULL
)	NULL
and	NULL
subsequently	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

The	NULL
quadrant	NULL
lines	NULL
were	NULL
set	NULL
by	NULL
the	NULL
background	NULL
signals	NULL
obtained	NULL
with	NULL
isotype-matched	NULL
negative	NULL
controls	NULL
.	NULL

Percentages	NULL
of	NULL
cells	NULL
found	NULL
in	NULL
each	NULL
quadrant	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
histograms	NULL
(	NULL
bottom	NULL
)	NULL
show	NULL
CD3	NULL
(	NULL
EDC	NULL
)	NULL
surface	NULL
staining	NULL
of	NULL
each	NULL
thymocyte	NULL
population	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
CD3	NULL
cells	NULL
.	NULL

This	NULL
experiment	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
performed	NULL
on	NULL
three	NULL
different	NULL
thymuses	NULL
.	NULL

0.4	NULL
ug	NULL
of	NULL
sonicated	NULL
salmon	NULL
sperm	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
protein	NULL
extract	NULL
,	NULL
and	NULL
30,000	NULL
cpm	NULL
of	NULL
*°P-labelled	NULL
DNA	NULL
probe	NULL
(	NULL
corresponding	NULL
to	NULL
0.25	NULL
ng	NULL
of	NULL
probe	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
oligonucleotides	NULL
used	NULL
was	NULL
5	NULL
'	NULL
GACAGAGGGGGACTTTCCGAcAGG	NULL
GTCTCCCCTGAAAGGCTCTCCCT	NULL
5	NULL
'	NULL
where	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
binding	NULL
sequence	NULL
is	NULL
indicated	NULL
in	NULL
bold	NULL
type	NULL
.	NULL

Specific	NULL
binding	NULL
was	NULL
controlled	NULL
by	NULL
competition	NULL
with	NULL
a	NULL
40-fold	NULL
excess	NULL
(	NULL
10	NULL
ng	NULL
)	NULL
of	NULL
the	NULL
same	NULL
nonlabeled	NULL
oligonucleotide	NULL
added	NULL
to	NULL
the	NULL
protein	NULL
extract	NULL
before	NULL
starting	NULL
the	NULL
binding	NULL
reaction	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
subunits	NULL
constituting	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
,	NULL
specific	NULL
antibodies	NULL
against	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
ReIB	NULL
were	NULL
used	NULL
.	NULL

p50	NULL
and	NULL
p65	NULL
antibodies	NULL
were	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
A.	NULL
Israél	NULL
(	NULL
Pasteur	NULL
Institute	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
,	NULL
and	NULL
ReIB	NULL
antibody	NULL
was	NULL
provided	NULL
by	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Antibodies	NULL
were	NULL
added	NULL
to	NULL
the	NULL
protein	NULL
extract	NULL
,	NULL
and	NULL
the	NULL
mixture	NULL
was	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
4°C	NULL
before	NULL
further	NULL
incubation	NULL
with	NULL
the	NULL
radiolabeled	NULL
probe	NULL
.	NULL

Statistical	NULL
analysis	NULL
.	NULL

The	NULL
relative	NULL
role	NULL
of	NULL
each	NULL
cytokine	NULL
in	NULL
HIV	NULL
replication	NULL
within	NULL
a	NULL
given	NULL
thymocyte	NULL
subpopulation	NULL
was	NULL
statistically	NULL
analyzed	NULL
by	NULL
the	NULL
nonparametric	NULL
test	NULL
of	NULL
Mann-Whitney	NULL
.	NULL

The	NULL
level	NULL
of	NULL
significance	NULL
was	NULL
set	NULL
at	NULL
P	NULL
=	NULL
0.05	NULL
.	NULL

RESULTS	NULL
Enrichment	NULL
of	NULL
CD4*	NULL
thymocyte	NULL
subpopulations	NULL
.	NULL

To	NULL
study	NULL
whether	NULL
the	NULL
high-level	NULL
replication	NULL
observed	NULL
in	NULL
total	NULL
thymocytes	NULL
in	NULL
coculture	NULL
with	NULL
TEC	NULL
is	NULL
a	NULL
feature	NULL
only	NULL
of	NULL
a	NULL
specific	NULL
thymocyte	NULL
subset	NULL
defined	NULL
by	NULL
the	NULL
maturation	NULL
state	NULL
,	NULL
we	NULL
enriched	NULL
the	NULL
distinct	NULL
thymocyte	NULL
subpopulations	NULL
expressing	NULL
CD4	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cell	NULL
activation	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Figure	NULL
1	NULL
represents	NULL
the	NULL
characterization	NULL
by	NULL
flow	NULL
cytometry	NULL
analysis	NULL
of	NULL
these	NULL
enriched	NULL
subpopulations	NULL
according	NULL
to	NULL
their	NULL
surface	NULL
expression	NULL
of	NULL
CD4	NULL
,	NULL
CD8	NULL
,	NULL
and	NULL
CD3	NULL
.	NULL

Immature	NULL
CD4	NULL
*	NULL
thymocytes	NULL
were	NULL
enriched	NULL
by	NULL
negative	NULL
selection	NULL
of	NULL
total	NULL
thymocytes	NULL
with	NULL
antibodies	NULL
against	NULL
CD8	NULL
and	NULL
CD3	NULL
,	NULL
to	NULL
discard	NULL
the	NULL
mature	NULL
CD4*	NULL
CD8~	NULL
CD3*	NULL
and	NULL
the	NULL
DP	NULL
CD4*	NULL
CD8*	NULL
thymocytes	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
this	NULL
immature	NULL
population	NULL
was	NULL
composed	NULL
of	NULL
two	NULL
main	NULL
subsets	NULL
previously	NULL
described	NULL
in	NULL
the	NULL
human	NULL
thymus	NULL
(	NULL
33	NULL
)	NULL
:	NULL
the	NULL
immature	NULL
triple-negative	NULL
(	NULL
TN	NULL
)	NULL
subset	NULL
(	NULL
CD4~	NULL
CD8~	NULL
CD3	NULL
)	NULL
and	NULL
the	NULL
intermediate	NULL
subset	NULL
(	NULL
CD4*	NULL
CD8~	NULL
CD3~	NULL
)	NULL
,	NULL
which	NULL
in	NULL
this	NULL
experiment	NULL
made	NULL
up	NULL
51	NULL
%	NULL
(	NULL
mean	NULL
,	NULL
38	NULL
%	NULL
+	NULL
10.6	NULL
%	NULL
for	NULL
13	NULL
thymuses	NULL
)	NULL
and	NULL
48	NULL
%	NULL
(	NULL
mean	NULL
,	NULL
57.3	NULL
+	NULL
10.8	NULL
%	NULL
for	NULL
13	NULL
thymuses	NULL
)	NULL
of	NULL
the	NULL
thymocytes	NULL
,	NULL
respectively	NULL
.	NULL

Enrichment	NULL
for	NULL
DP	NULL
thymocytes	NULL
was	NULL
performed	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorting	NULL
with	NULL
CD4	NULL
and	NULL
CD8	NULL
antibodies	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
an	NULL
enrichment	NULL
of	NULL
94	NULL
%	NULL
was	NULL
obtained	NULL
.	NULL

CD3	NULL
expression	NULL
was	NULL
observed	NULL
in	NULL
55	NULL
%	NULL
of	NULL
cells	NULL
at	NULL
an	NULL
intermediate	NULL
level	NULL
and	NULL
in	NULL
15	NULL
%	NULL
at	NULL
a	NULL
high	NULL
level	NULL
.	NULL

However	NULL
,	NULL
this	NULL
high	NULL
level	NULL
does	NULL
not	NULL
reach	NULL
the	NULL
maximum	NULL
level	NULL
observed	NULL
in	NULL
the	NULL
mature	NULL
population	NULL
.	NULL

We	NULL
developed	NULL
a	NULL
new	NULL
technique	NULL
for	NULL
enrichment	NULL
of	NULL
the	NULL
mature	NULL
CD4	NULL
*	NULL
CD8~	NULL
CD3	NULL
*	NULL
thymocytes	NULL
.	NULL

We	NULL
performed	NULL
a	NULL
negative	NULL
selection	NULL
with	NULL
CD8	NULL
,	NULL
CD34	NULL
,	NULL
and	NULL
CD10	NULL
antibodies	NULL
.	NULL

CD34	NULL
is	NULL
expressed	NULL
on	NULL
very	NULL
immature	NULL
thymocytes	NULL
(	NULL
18	NULL
)	NULL
,	NULL
and	NULL
CD10	NULL
is	NULL
expressed	NULL
early	NULL
during	NULL
thymocyte	NULL
development	NULL
but	NULL
decreases	NULL
with	NULL
the	NULL
increase	NULL
of	NULL
CD3	NULL
expression	NULL
at	NULL
the	NULL
DP	NULL
stage	NULL
(	NULL
54	NULL
)	NULL
.	NULL

The	NULL
CD4*	NULL
mature	NULL
population	NULL
in	NULL
the	NULL
experiment	NULL
in	NULL
Fig	NULL
.	NULL

1D	NULL
was	NULL
more	NULL
than	NULL
94	NULL
%	NULL
(	NULL
mean	NULL
,	NULL
90.8	NULL
+	NULL
2.9	NULL
%	NULL
for	NULL
eight	NULL
thymuses	NULL
)	NULL
CD3	NULL
``	NULL
®	NULL
``	NULL
and	NULL
more	NULL
than	NULL
90	NULL
%	NULL
CD69	NULL
``	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Only	NULL
6.6	NULL
%	NULL
(	NULL
mean	NULL
,	NULL
9.7	NULL
+	NULL
4.8	NULL
for	NULL
eight	NULL
thymuses	NULL
)	NULL
of	NULL
these	NULL
cells	NULL
had	NULL
an	NULL
undetectable	NULL
level	NULL
of	NULL
CD4	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1D	NULL
.	NULL

The	NULL
mature	NULL
CD4	NULL
unstained	NULL
thymocytes	NULL
,	NULL
could	NULL
be	NULL
depleted	NULL
by	NULL
using	NULL
an	NULL
antibody	NULL
against	NULL
CD4	NULL
,	NULL
suggesting	NULL
that	NULL
they	NULL
also	NULL
express	NULL
CD4	NULL
but	NULL
at	NULL
a	NULL
low	NULL
level	NULL
.	NULL

7536	NULL
CHENE	NULL
ET	NULL
AL	NULL
.	NULL

30	NULL
Mature	NULL
CD4*CD	NULL
#	NULL
CD3+	NULL
E	NULL
2	NULL
®	NULL
2	NULL
sn	NULL
4	NULL
bus	NULL
al	NULL
m	NULL
10	NULL
Total	NULL
0	NULL
DP	NULL
CD4+	NULL
CD8+	NULL
CD3	NULL
``	NULL
3	NULL
6	NULL
9	NULL
12	NULL
15	NULL
Immature	NULL
CD4*CD8	NULL
CD3	NULL
Days	NULL
post	NULL
infection	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Interaction	NULL
with	NULL
TEC	NULL
favors	NULL
high-level	NULL
HIV	NULL
replication	NULL
exclusively	NULL
in	NULL
mature	NULL
CD4*	NULL
CD8~	NULL
CD3	NULL
*	NULL
thymocytes	NULL
.	NULL

Freshly	NULL
isolated	NULL
total	NULL
,	NULL
immature	NULL
CD4~	NULL
CD8~	NULL
CD3~	NULL
,	NULL
double-positive	NULL
CD4*	NULL
CD8	NULL
``	NULL
CD3®	NULL
,	NULL
or	NULL
mature	NULL
CD4*	NULL
CD8~	NULL
CD3*	NULL
thymocytes	NULL
were	NULL
infected	NULL
by	NULL
HIV-15	NULL
1	NULL
aj	NULL
,	NULL
at	NULL
a	NULL
multiplicity	NULL
of	NULL
infection	NULL
of	NULL
0.001	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Each	NULL
subpopulation	NULL
was	NULL
cocultured	NULL
with	NULL
autologous	NULL
TEC	NULL
,	NULL
and	NULL
HIV	NULL
replication	NULL
was	NULL
determined	NULL
by	NULL
measuring	NULL
the	NULL
p24°	NULL
``	NULL
®	NULL
concentration	NULL
in	NULL
the	NULL
coculture	NULL
supernatants	NULL
on	NULL
days	NULL
3	NULL
,	NULL
6	NULL
,	NULL
10	NULL
,	NULL
13	NULL
,	NULL
and	NULL
17	NULL
postinfection	NULL
.	NULL

This	NULL
experiment	NULL
is	NULL
representative	NULL
of	NULL
four	NULL
experiments	NULL
performed	NULL
on	NULL
four	NULL
thymuses	NULL
.	NULL

Ag	NULL
,	NULL
antigen	NULL
.	NULL

Interaction	NULL
with	NULL
TEC	NULL
favors	NULL
HIV	NULL
replication	NULL
exclusively	NULL
in	NULL
the	NULL
mature	NULL
CD4*	NULL
CD8~	NULL
CD3+	NULL
thymocytes	NULL
.	NULL

We	NULL
first	NULL
tested	NULL
whether	NULL
the	NULL
individually	NULL
enriched	NULL
CD4*	NULL
subpopulations	NULL
of	NULL
thymocytes	NULL
were	NULL
capable	NULL
of	NULL
producing	NULL
HIV	NULL
at	NULL
a	NULL
high	NULL
level	NULL
when	NULL
cocultured	NULL
with	NULL
TEC	NULL
.	NULL

Total	NULL
thymocytes	NULL
as	NULL
well	NULL
as	NULL
subpopulations	NULL
containing	NULL
predominantly	NULL
DP	NULL
CD4¢~	NULL
CD8*	NULL
CD3*	NULL
,	NULL
immature	NULL
CD4~	NULL
CD8~	NULL
CD3~	NULL
,	NULL
and	NULL
mature	NULL
CD4*	NULL
CD8~	NULL
CD3	NULL
*	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
the	NULL
primary	NULL
HIV-	NULL
!	NULL

p	NULL
ramp	NULL
isolate	NULL
and	NULL
cultured	NULL
alone	NULL
or	NULL
cocultured	NULL
with	NULL
autologous	NULL
TEC	NULL
.	NULL

HIV-1	NULL
replication	NULL
was	NULL
evaluated	NULL
by	NULL
measuring	NULL
the	NULL
p24°**	NULL
antigen	NULL
concentration	NULL
in	NULL
the	NULL
culture	NULL
supernatants	NULL
at	NULL
various	NULL
times	NULL
postinfection	NULL
.	NULL

No	NULL
HIV	NULL
replication	NULL
was	NULL
detected	NULL
when	NULL
total	NULL
thymocytes	NULL
or	NULL
any	NULL
of	NULL
the	NULL
CD4*	NULL
subpopulations	NULL
were	NULL
cultured	NULL
A	NULL
150	NULL
Mature	NULL
CD4*CD§	NULL
:	NULL
CD3+	NULL
-=	NULL
100	NULL
&	NULL
``	NULL
cp	NULL
Sn	NULL
Immature	NULL
<	NULL
4	NULL
CD4CD§CD3	NULL
<	NULL
p	NULL
-	NULL
50	NULL
ea	NULL
Ca	NULL
Total	NULL
0	NULL
DP	NULL
CD4*CDS8*CD3~+	NULL
3	NULL
7	NULL
10	NULL
©	NULL
13	NULL
Days	NULL
post	NULL
infection	NULL
J.	NULL
Virou	NULL
.	NULL

in	NULL
the	NULL
absence	NULL
of	NULL
TEC	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
an	NULL
efficient	NULL
HIV	NULL
replication	NULL
was	NULL
observed	NULL
in	NULL
coculture	NULL
of	NULL
autologous	NULL
TEC	NULL
with	NULL
total	NULL
thymocytes	NULL
and	NULL
exclusively	NULL
with	NULL
the	NULL
subset	NULL
of	NULL
mature	NULL
CD4*	NULL
CD8~	NULL
CD3*	NULL
thymocytes	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Under	NULL
our	NULL
coculture	NULL
conditions	NULL
,	NULL
the	NULL
observed	NULL
replication	NULL
level	NULL
for	NULL
mature	NULL
thymocytes	NULL
obtained	NULL
from	NULL
nine	NULL
thymuses	NULL
corresponded	NULL
to	NULL
1.5	NULL
to	NULL
33	NULL
ng	NULL
of	NULL
p24°*	NULL
per	NULL
ml	NULL
.	NULL

In	NULL
each	NULL
thymus	NULL
,	NULL
the	NULL
level	NULL
of	NULL
replication	NULL
observed	NULL
in	NULL
this	NULL
specific	NULL
subset	NULL
was	NULL
about	NULL
5-to	NULL
20-fold	NULL
higher	NULL
than	NULL
that	NULL
observed	NULL
in	NULL
total	NULL
thymocytes	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
worth	NULL
pointing	NULL
out	NULL
that	NULL
virus	NULL
entry	NULL
was	NULL
not	NULL
impaired	NULL
within	NULL
the	NULL
DP	NULL
and	NULL
immature	NULL
thymocytes	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
PCR	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

CD4*	NULL
CDS8~	NULL
CD3*	NULL
as	NULL
well	NULL
as	NULL
intermediate	NULL
CD4*	NULL
CD8~	NULL
CD3~	NULL
thymocytes	NULL
sustain	NULL
a	NULL
high-level	NULL
HIV	NULL
replication	NULL
in	NULL
response	NULL
to	NULL
specific	NULL
cytokines	NULL
required	NULL
for	NULL
HIV	NULL
replication	NULL
.	NULL

The	NULL
cytokines	NULL
mainly	NULL
involved	NULL
in	NULL
HIV	NULL
replication	NULL
in	NULL
total	NULL
thymocytes	NULL
during	NULL
their	NULL
interaction	NULL
with	NULL
TEC	NULL
were	NULL
previously	NULL
determined	NULL
as	NULL
TNF	NULL
,	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
GM-CSF	NULL
(	NULL
45	NULL
)	NULL
,	NULL
and	NULL
IL-7	NULL
(	NULL
14	NULL
)	NULL
.	NULL

We	NULL
first	NULL
determined	NULL
whether	NULL
addition	NULL
of	NULL
these	NULL
cytokines	NULL
was	NULL
sufficient	NULL
to	NULL
promote	NULL
HIV	NULL
replication	NULL
in	NULL
the	NULL
mature	NULL
CD4*	NULL
CD8~	NULL
CD3	NULL
*	NULL
subset	NULL
.	NULL

In	NULL
parallel	NULL
,	NULL
we	NULL
studied	NULL
whether	NULL
the	NULL
absence	NULL
of	NULL
HIV	NULL
replication	NULL
in	NULL
the	NULL
DP	NULL
and	NULL
the	NULL
immature	NULL
subsets	NULL
during	NULL
their	NULL
interaction	NULL
with	NULL
TEC	NULL
was	NULL
related	NULL
to	NULL
a	NULL
possible	NULL
unresponsiveness	NULL
to	NULL
these	NULL
cytokines	NULL
.	NULL

Therefore	NULL
,	NULL
total	NULL
thymocytes	NULL
,	NULL
mature	NULL
CD4	NULL
CD8~	NULL
CD3¢	NULL
,	NULL
DP	NULL
CD4*	NULL
CD8*	NULL
CD3®	NULL
,	NULL
and	NULL
immature	NULL
CD4*	NULL
CD8~	NULL
CD3~	NULL
thymocytes	NULL
were	NULL
infected	NULL
with	NULL
HIV-1	NULL
;	NULL
,	NULL
;	NULL
;	NULL
,	NULL
and	NULL
were	NULL
cultured	NULL
in	NULL
absence	NULL
of	NULL
TEC	NULL
but	NULL
treated	NULL
with	NULL
a	NULL
mixture	NULL
of	NULL
TNF	NULL
,	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
IL-7	NULL
,	NULL
and	NULL
GM-CSF	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
the	NULL
role	NULL
of	NULL
these	NULL
cytokines	NULL
in	NULL
inducing	NULL
HIV	NULL
replication	NULL
in	NULL
total	NULL
thymocytes	NULL
was	NULL
confirmed	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
a	NULL
5-	NULL
to	NULL
20-fold-increased	NULL
replication	NULL
(	NULL
between	NULL
5	NULL
and	NULL
130	NULL
ng	NULL
for	NULL
eight	NULL
thymuses	NULL
)	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
mature	NULL
CD8~	NULL
CD3	NULL
``	NULL
subset	NULL
under	NULL
these	NULL
conditions	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

In	NULL
the	NULL
experiment	NULL
represented	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
despite	NULL
an	NULL
especially	NULL
high-level	NULL
replication	NULL
in	NULL
total	NULL
and	NULL
mature	NULL
thymocytes	NULL
,	NULL
no	NULL
detectable	NULL
replication	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
DP	NULL
subset	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
immature	NULL
pool	NULL
of	NULL
thymocytes	NULL
,	NULL
although	NULL
unable	NULL
B	NULL
157	NULL
Intermediate	NULL
1	NULL
TN	NULL
CD4CDS	NULL
CD3	NULL
:	NULL
mmature	NULL
104	NULL
5.	NULL
o	NULL
TN	NULL
CD4CD8	NULL
CDJ	NULL
3	NULL
6	NULL
10	NULL
14	NULL
Days	NULL
post	NULL
infection	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

The	NULL
mature	NULL
CD4*	NULL
CD8~	NULL
CD3*	NULL
but	NULL
also	NULL
the	NULL
intermediate	NULL
CD4*	NULL
CD87	NULL
CD3~	NULL
thymocytes	NULL
sustain	NULL
high-level	NULL
HIV	NULL
replication	NULL
under	NULL
stimulation	NULL
with	NULL
the	NULL
mixture	NULL
of	NULL
cytokines	NULL
(	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
IL-7	NULL
,	NULL
GM-CSF	NULL
,	NULL
and	NULL
TNF	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Freshly	NULL
isolated	NULL
total	NULL
,	NULL
immature	NULL
CD4*	NULL
CD8~	NULL
CD37	NULL
,	NULL
double-positive	NULL
CD4*	NULL
CD8*	NULL
CD3~	NULL
,	NULL
and	NULL
mature	NULL
CD4*	NULL
CD8~	NULL
CD3*	NULL
thymocytes	NULL
were	NULL
infected	NULL
by	NULL
the	NULL
HIV-13	NULL
;	NULL
aj	NULL
,	NULL
isolate	NULL
at	NULL
a	NULL
multiplicity	NULL
of	NULL
infection	NULL
of	NULL
0.001	NULL
.	NULL

They	NULL
were	NULL
cultured	NULL
with	NULL
stimulation	NULL
by	NULL
a	NULL
mixture	NULL
of	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
IL-7	NULL
,	NULL
GM-CSF	NULL
,	NULL
and	NULL
TNF	NULL
.	NULL

HIV	NULL
replication	NULL
was	NULL
determined	NULL
by	NULL
measuring	NULL
the	NULL
p24	NULL
``	NULL
concentration	NULL
in	NULL
the	NULL
coculture	NULL
supernatants	NULL
on	NULL
days	NULL
3	NULL
,	NULL
7	NULL
,	NULL
10	NULL
,	NULL
and	NULL
14	NULL
postinfection	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Immature	NULL
CD4*	NULL
CD87	NULL
CD3~	NULL
thymocytes	NULL
(	NULL
including	NULL
intermediate	NULL
CD4*	NULL
CD87	NULL
CD3~	NULL
and	NULL
TN	NULL
CD4~	NULL
CD8~	NULL
CD3~	NULL
)	NULL
or	NULL
immature	NULL
thymocytes	NULL
depleted	NULL
from	NULL
CD4*	NULL
cells	NULL
resulting	NULL
in	NULL
the	NULL
TN	NULL
CD4~	NULL
CD8~	NULL
CD3~	NULL
subset	NULL
were	NULL
infected	NULL
by	NULL
HIV-1	NULL
,	NULL
;	NULL
a	NULL
;	NULL
,	NULL
at	NULL
a	NULL
multiplicity	NULL
of	NULL
infection	NULL
of	NULL
0.001	NULL
and	NULL
cultured	NULL
with	NULL
stimulation	NULL
by	NULL
a	NULL
mixture	NULL
of	NULL
cytokines	NULL
(	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
IL-7	NULL
,	NULL
GM-CSF	NULL
,	NULL
and	NULL
TNF	NULL
)	NULL
.	NULL

HIV	NULL
replication	NULL
was	NULL
determined	NULL
by	NULL
measuring	NULL
the	NULL
p24°**	NULL
concentration	NULL
in	NULL
the	NULL
coculture	NULL
supernatants	NULL
on	NULL
days	NULL
3	NULL
,	NULL
6	NULL
,	NULL
10	NULL
,	NULL
and	NULL
14	NULL
postinfection	NULL
.	NULL

This	NULL
pattern	NULL
of	NULL
response	NULL
of	NULL
the	NULL
different	NULL
subpopulations	NULL
to	NULL
the	NULL
cytokines	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
performed	NULL
on	NULL
three	NULL
different	NULL
thymuses	NULL
.	NULL

voL	NULL
.	NULL

73	NULL
,	NULL
1999	NULL
A	NULL
Total	NULL
2	NULL
6	NULL
1,5	NULL
TE	NULL
.	NULL

4	NULL
``	NULL
cb	NULL
A	NULL
so	NULL
1	NULL
<	NULL
4	NULL
f	NULL
A	NULL
2	NULL
0,5	NULL
0	NULL
0	NULL
4	NULL
6	NULL
8	NULL
10	NULL
4	NULL
6	NULL
8	NULL
B	NULL
Mature	NULL
CD4	NULL
+	NULL
CD8-CD3+*	NULL
Days	NULL
post	NULL
infection	NULL
HIV	NULL
REPLICATION	NULL
IN	NULL
CD4*	NULL
THYMOCYTES	NULL
-	NULL
7537	NULL
C	NULL
Immature	NULL
CD4/*CD8CD3	NULL
:	NULL
10	NULL
-B-	NULL
all	NULL
cytokines	NULL
7,5	NULL
-	NULL
&	NULL
-	NULL
minus	NULL
IL1	NULL
5	NULL
-A-	NULL
minus	NULL
IL6	NULL
2,5	NULL
-O-	NULL
minus	NULL
GM-CSF	NULL
-O-	NULL
minus	NULL
TNF	NULL
-	NULL
@	NULL
-	NULL
minus	NULL
IL7	NULL
10	NULL
4	NULL
6	NULL
8	NULL
10	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

TNF	NULL
and	NULL
IL-7	NULL
play	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
mature	NULL
CD4*	NULL
CD87	NULL
CD3*	NULL
and	NULL
in	NULL
immature	NULL
CD4*	NULL
CD87	NULL
CD3~	NULL
thymocytes	NULL
,	NULL
whereas	NULL
GM-CSF	NULL
is	NULL
a	NULL
major	NULL
factor	NULL
only	NULL
in	NULL
immature	NULL
thymocytes	NULL
.	NULL

Each	NULL
population	NULL
used	NULL
in	NULL
this	NULL
experiment	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
total	NULL
(	NULL
A	NULL
)	NULL
,	NULL
mature	NULL
CD4*	NULL
CD87	NULL
CD3*	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
immature	NULL
CD4*	NULL
CD8~	NULL
CD3~	NULL
(	NULL
C	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
a	NULL
different	NULL
thymus	NULL
.	NULL

Thymocytes	NULL
of	NULL
each	NULL
population	NULL
were	NULL
infected	NULL
by	NULL
HIV-1g	NULL
{	NULL
aj	NULL
,	NULL
at	NULL
a	NULL
multiplicity	NULL
of	NULL
infection	NULL
of	NULL
0.001	NULL
,	NULL
were	NULL
seeded	NULL
at	NULL
2	NULL
x	NULL
10°	NULL
cells/ml	NULL
,	NULL
and	NULL
cultured	NULL
with	NULL
the	NULL
mixture	NULL
of	NULL
cytokines	NULL
(	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
IL-7	NULL
,	NULL
GM-CSF	NULL
,	NULL
and	NULL
TNF	NULL
)	NULL
or	NULL
with	NULL
this	NULL
mixture	NULL
including	NULL
all	NULL
but	NULL
one	NULL
of	NULL
these	NULL
cytokines	NULL
.	NULL

HIV	NULL
replication	NULL
was	NULL
determined	NULL
by	NULL
measuring	NULL
the	NULL
p24®**	NULL
concentration	NULL
in	NULL
the	NULL
culture	NULL
supernatants	NULL
on	NULL
various	NULL
days	NULL
postinfection	NULL
.	NULL

For	NULL
each	NULL
subpopulation	NULL
,	NULL
this	NULL
experiment	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
performed	NULL
with	NULL
three	NULL
different	NULL
thymuses	NULL
.	NULL

Statistical	NULL
analysis	NULL
by	NULL
the	NULL
nonparametric	NULL
test	NULL
of	NULL
Mann-Whitney	NULL
gave	NULL
the	NULL
following	NULL
significant	NULL
differences	NULL
between	NULL
the	NULL
different	NULL
cytokine	NULL
mixtures	NULL
:	NULL
for	NULL
total	NULL
thymocytes	NULL
with	NULL
all	NULL
cytokines	NULL
versus	NULL
total	NULL
thymocytes	NULL
minus	NULL
IL-7	NULL
,	NULL
P	NULL
<	NULL
0.006	NULL
;	NULL
for	NULL
all	NULL
cytokines	NULL
versus	NULL
minus	NULL
GM-CSF	NULL
,	NULL
P	NULL
<	NULL
0.006	NULL
;	NULL
and	NULL
for	NULL
all	NULL
cytokines	NULL
versus	NULL
minus	NULL
TNF	NULL
,	NULL
P	NULL
<	NULL
0.006	NULL
;	NULL
for	NULL
mature	NULL
thymocytes	NULL
with	NULL
all	NULL
cytokines	NULL
versus	NULL
minus	NULL
IL-7	NULL
,	NULL
P	NULL
<	NULL
0.02	NULL
;	NULL
for	NULL
all	NULL
cytokines	NULL
versus	NULL
minus	NULL
IL-6	NULL
,	NULL
P	NULL
<	NULL
0.02	NULL
;	NULL
and	NULL
for	NULL
all	NULL
cytokines	NULL
versus	NULL
minus	NULL
TNF	NULL
,	NULL
P	NULL
<	NULL
0.02	NULL
;	NULL
for	NULL
the	NULL
immature	NULL
thymocytes	NULL
with	NULL
all	NULL
cytokines	NULL
versus	NULL
minus	NULL
IL-7	NULL
,	NULL
P	NULL
<	NULL
0.006	NULL
;	NULL
for	NULL
all	NULL
cytokines	NULL
versus	NULL
minus	NULL
GM-CSF	NULL
,	NULL
P	NULL
<	NULL
0.006	NULL
;	NULL
and	NULL
for	NULL
all	NULL
cytokines	NULL
versus	NULL
minus	NULL
TNF	NULL
,	NULL
P	NULL
<	NULL
0.01.	NULL
to	NULL
produce	NULL
the	NULL
virus	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TEC	NULL
,	NULL
was	NULL
able	NULL
to	NULL
do	NULL
so	NULL
when	NULL
stimulated	NULL
with	NULL
these	NULL
cytokines	NULL
.	NULL

Because	NULL
the	NULL
immature	NULL
population	NULL
consists	NULL
of	NULL
two	NULL
different	NULL
thymocyte	NULL
subsets	NULL
(	NULL
as	NULL
mentioned	NULL
above	NULL
)	NULL
,	NULL
we	NULL
determined	NULL
whether	NULL
this	NULL
high-level	NULL
replication	NULL
took	NULL
place	NULL
either	NULL
in	NULL
the	NULL
TN	NULL
CD4~	NULL
CD8~	NULL
CD3~	NULL
or	NULL
in	NULL
the	NULL
intermediate	NULL
CD4*	NULL
CD8~	NULL
CD3~	NULL
subset	NULL
or	NULL
in	NULL
both	NULL
.	NULL

We	NULL
considered	NULL
the	NULL
TN	NULL
subset	NULL
because	NULL
the	NULL
permissivity	NULL
of	NULL
these	NULL
cells	NULL
was	NULL
previously	NULL
reported	NULL
in	NULL
relation	NULL
to	NULL
low	NULL
CD4	NULL
expression	NULL
under	NULL
conditions	NULL
of	NULL
stimulation	NULL
by	NULL
mitogen	NULL
(	NULL
57	NULL
)	NULL
.	NULL

The	NULL
TN	NULL
subset	NULL
was	NULL
isolated	NULL
by	NULL
depleting	NULL
the	NULL
immature	NULL
subset	NULL
from	NULL
CD4	NULL
*	NULL
cells	NULL
by	NULL
negative	NULL
selection	NULL
with	NULL
CD4	NULL
antibodies	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
the	NULL
high-level	NULL
HIV	NULL
replication	NULL
observed	NULL
in	NULL
the	NULL
immature	NULL
subset	NULL
when	NULL
they	NULL
were	NULL
treated	NULL
with	NULL
cytokines	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
the	NULL
TN	NULL
subset	NULL
and	NULL
therefore	NULL
must	NULL
have	NULL
been	NULL
restricted	NULL
to	NULL
the	NULL
intermediate	NULL
CD4*~	NULL
CD8~	NULL
CD3~	NULL
subset	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

We	NULL
then	NULL
evaluated	NULL
the	NULL
relative	NULL
importance	NULL
of	NULL
each	NULL
of	NULL
these	NULL
cytokines	NULL
in	NULL
promoting	NULL
HIV	NULL
replication	NULL
in	NULL
total	NULL
thymocytes	NULL
and	NULL
in	NULL
the	NULL
two	NULL
responsive	NULL
subsets	NULL
,	NULL
namely	NULL
,	NULL
the	NULL
mature	NULL
CD4	NULL
*	NULL
CD8~	NULL
CD3	NULL
*	NULL
and	NULL
the	NULL
intermediate	NULL
CD4*	NULL
CD8~	NULL
CD3	NULL
.	NULL

Due	NULL
to	NULL
the	NULL
need	NULL
for	NULL
a	NULL
large	NULL
number	NULL
of	NULL
cells	NULL
,	NULL
each	NULL
population	NULL
used	NULL
in	NULL
this	NULL
experiment	NULL
was	NULL
obtained	NULL
from	NULL
a	NULL
different	NULL
thymus	NULL
.	NULL

The	NULL
total	NULL
population	NULL
,	NULL
the	NULL
mature	NULL
subset	NULL
,	NULL
and	NULL
the	NULL
immature	NULL
CD4*	NULL
CD8~	NULL
CD3~	NULL
pool	NULL
(	NULL
in	NULL
which	NULL
only	NULL
the	NULL
intermediate	NULL
thymocytes	NULL
replicate	NULL
the	NULL
virus	NULL
)	NULL
were	NULL
infected	NULL
by	NULL
HIV-1	NULL
;	NULL
;	NULL
aj	NULL
,	NULL
and	NULL
cultured	NULL
at	NULL
2	NULL
X	NULL
10°/well	NULL
with	NULL
either	NULL
the	NULL
mixture	NULL
of	NULL
all	NULL
cytokines	NULL
(	NULL
TNF	NULL
,	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
IL-7	NULL
,	NULL
and	NULL
GM-CSF	NULL
)	NULL
or	NULL
with	NULL
mixtures	NULL
which	NULL
each	NULL
lacked	NULL
one	NULL
specific	NULL
cytokine	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
we	NULL
confirmed	NULL
a	NULL
crucial	NULL
role	NULL
of	NULL
TNF	NULL
and	NULL
IL-7	NULL
in	NULL
sustaining	NULL
HIV	NULL
replication	NULL
in	NULL
total	NULL
thymocytes	NULL
,	NULL
since	NULL
no	NULL
detectable	NULL
replication	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
either	NULL
one	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
GM-CSF	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
reduction	NULL
of	NULL
HIV	NULL
replication	NULL
.	NULL

Comparison	NULL
of	NULL
Fig	NULL
.	NULL

4B	NULL
and	NULL
C	NULL
shows	NULL
that	NULL
TNF	NULL
and	NULL
IL-7	NULL
appear	NULL
to	NULL
play	NULL
the	NULL
same	NULL
crucial	NULL
role	NULL
in	NULL
mature	NULL
and	NULL
immature	NULL
thymocytes	NULL
whereas	NULL
GM-CSF	NULL
is	NULL
an	NULL
additional	NULL
major	NULL
factor	NULL
only	NULL
in	NULL
immature	NULL
thymocytes	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
IL-1	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
HIV	NULL
replication	NULL
in	NULL
either	NULL
subpopulation	NULL
,	NULL
whereas	NULL
the	NULL
absence	NULL
of	NULL
IL-6	NULL
impaired	NULL
the	NULL
replication	NULL
in	NULL
the	NULL
mature	NULL
thymocytes	NULL
exclusively	NULL
.	NULL

TNF	NULL
secreted	NULL
during	NULL
interaction	NULL
of	NULL
thymocytes	NULL
with	NULL
TEC	NULL
is	NULL
crucial	NULL
in	NULL
inducing	NULL
NF-B-dependent	NULL
replication	NULL
since	NULL
its	NULL
absence	NULL
during	NULL
the	NULL
specific	NULL
interaction	NULL
between	NULL
intermediate	NULL
thymocytes	NULL
and	NULL
TEC	NULL
is	NULL
responsible	NULL
for	NULL
an	NULL
impaired	NULL
replication	NULL
.	NULL

Since	NULL
the	NULL
lack	NULL
of	NULL
a	NULL
high-level	NULL
HIV	NULL
replication	NULL
within	NULL
the	NULL
intermediate	NULL
subset	NULL
was	NULL
not	NULL
due	NULL
to	NULL
their	NULL
unresponsiveness	NULL
to	NULL
the	NULL
specific	NULL
cytokines	NULL
required	NULL
for	NULL
replication	NULL
,	NULL
we	NULL
examined	NULL
an	NULL
alternative	NULL
hypothesis	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
that	NULL
of	NULL
a	NULL
defect	NULL
in	NULL
the	NULL
secretion	NULL
of	NULL
one	NULL
or	NULL
more	NULL
of	NULL
these	NULL
cytokines	NULL
during	NULL
intermediate	NULL
thymocyte-TEC	NULL
interaction	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
first	NULL
performed	NULL
experiments	NULL
in	NULL
which	NULL
the	NULL
cytokines	NULL
exhibiting	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
the	NULL
immature	NULL
subset	NULL
(	NULL
TNF	NULL
,	NULL
IL-7	NULL
,	NULL
and	NULL
GM-CSF	NULL
)	NULL
for	NULL
HIV	NULL
replication	NULL
were	NULL
added	NULL
,	NULL
individually	NULL
to	NULL
cocultures	NULL
of	NULL
infected	NULL
intermediate	NULL
thymocytes	NULL
with	NULL
TEC	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
of	NULL
the	NULL
three	NULL
factors	NULL
tested	NULL
,	NULL
only	NULL
TNF	NULL
was	NULL
able	NULL
to	NULL
promote	NULL
a	NULL
detectable	NULL
HIV	NULL
replication	NULL
in	NULL
the	NULL
coculture	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
TNF	NULL
is	NULL
not	NULL
secreted	NULL
or	NULL
is	NULL
secreted	NULL
in	NULL
insufficient	NULL
amounts	NULL
during	NULL
immature	NULL
thymocyte-TEC	NULL
interaction	NULL
.	NULL

In	NULL
our	NULL
previous	NULL
report	NULL
(	NULL
14	NULL
)	NULL
,	NULL
we	NULL
provided	NULL
evidence	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
factors	NULL
of	NULL
the	NULL
Rel/NF-	NULL
«	NULL
B	NULL
family	NULL
is	NULL
a	NULL
requirement	NULL
to	NULL
promote	NULL
efficient	NULL
HIV	NULL
replication	NULL
in	NULL
thymocytes	NULL
.	NULL

The	NULL
prevalent	NULL
NF-kB	NULL
complex	NULL
present	NULL
in	NULL
total	NULL
freshly	NULL
isolated	NULL
thymocytes	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
the	NULL
p50-p65	NULL
complex	NULL
,	NULL
whereas	NULL
p50-p50	NULL
and	NULL
p50-ReIB	NULL
complexes	NULL
,	NULL
although	NULL
present	NULL
,	NULL
were	NULL
less	NULL
strongly	NULL
represented	NULL
.	NULL

We	NULL
also	NULL
demonstrated	NULL
that	NULL
TNF	NULL
,	NULL
secreted	NULL
during	NULL
the	NULL
coculture	NULL
,	NULL
is	NULL
the	NULL
cytokine	NULL
mainly	NULL
involved	NULL
in	NULL
the	NULL
maintenance	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
and	NULL
that	NULL
TNF	NULL
signaling	NULL
requires	NULL
coactivation	NULL
by	NULL
IL-7	NULL
.	NULL

Here	NULL
we	NULL
first	NULL
verified	NULL
that	NULL
the	NULL
active	NULL
p50-p65	NULL
complex	NULL
actually	NULL
resides	NULL
in	NULL
mature	NULL
but	NULL
not	NULL
in	NULL
immature	NULL
thymocytes	NULL
.	NULL

NF-	NULL
«	NULL
kB	NULL
complexes	NULL
were	NULL
charac-terized	NULL
,	NULL
in	NULL
mature	NULL
CD4	NULL
CD8~	NULL
CD3	NULL
and	NULL
immature	NULL
CD4*	NULL
CD8~	NULL
CD3~	NULL
thymocytes	NULL
freshly	NULL
isolated	NULL
from	NULL
the	NULL
same	NULL
thymus	NULL
,	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
with	NULL
antibodies	NULL
7538	NULL
CHENE	NULL
ET	NULL
AL	NULL
.	NULL

500	NULL
TNF	NULL
400	NULL
5	NULL
,	NULL
300	NULL
-	NULL
``	NULL
5p	NULL
<	NULL
t	NULL
3	NULL
200	NULL
100	NULL
-	NULL
IL-7	NULL
Control	NULL
GM-CSF	NULL
0	NULL
I	NULL
I	NULL
U	NULL
6	NULL
8	NULL
10	NULL
12	NULL
Days	NULL
post-infection	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Defect	NULL
in	NULL
activation	NULL
of	NULL
TNF	NULL
secretion	NULL
during	NULL
the	NULL
TEC-immature-thymocyte	NULL
interaction	NULL
correlates	NULL
with	NULL
an	NULL
impairment	NULL
of	NULL
HIV	NULL
replication	NULL
in	NULL
the	NULL
immature	NULL
CD4*	NULL
CD8~	NULL
CD3~	NULL
thymocytes	NULL
.	NULL

Freshly	NULL
isolated	NULL
immature	NULL
CD4~	NULL
CD8~	NULL
CD3~	NULL
thymocytes	NULL
were	NULL
infected	NULL
by	NULL
the	NULL
HIV-1y	NULL
aj	NULL
,	NULL
isolate	NULL
at	NULL
a	NULL
multiplicity	NULL
of	NULL
infection	NULL
of	NULL
0.001	NULL
.	NULL

They	NULL
were	NULL
cocultured	NULL
with	NULL
autologous	NULL
TEC	NULL
with	NULL
no	NULL
additional	NULL
stimulation	NULL
(	NULL
Control	NULL
)	NULL
or	NULL
with	NULL
TNF	NULL
,	NULL
IL-7	NULL
,	NULL
or	NULL
GM-CSF	NULL
.	NULL

HIV	NULL
replication	NULL
was	NULL
determined	NULL
by	NULL
measuring	NULL
the	NULL
p24®*	NULL
concentration	NULL
in	NULL
the	NULL
culture	NULL
supernatants	NULL
on	NULL
various	NULL
days	NULL
postinfection	NULL
.	NULL

This	NULL
experiment	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
performed	NULL
on	NULL
three	NULL
different	NULL
thymuses	NULL
.	NULL

specific	NULL
for	NULL
the	NULL
different	NULL
members	NULL
of	NULL
this	NULL
family	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
in	NULL
the	NULL
freshly	NULL
isolated	NULL
CD4*	NULL
CD8~	NULL
CD3	NULL
*	NULL
thymocytes	NULL
,	NULL
antibodies	NULL
against	NULL
p50	NULL
abolished	NULL
the	NULL
binding	NULL
of	NULL
most	NULL
complexes	NULL
,	NULL
antibodies	NULL
against	NULL
p65	NULL
abolished	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
upper	NULL
complex	NULL
,	NULL
and	NULL
antibodies	NULL
against	NULL
RelB	NULL
did	NULL
not	NULL
modify	NULL
the	NULL
binding	NULL
of	NULL
any	NULL
complex	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
p50-p50	NULL
and	NULL
the	NULL
p50-p65	NULL
complexes	NULL
are	NULL
the	NULL
main	NULL
representatives	NULL
in	NULL
this	NULL
subset	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
in	NULL
freshly	NULL
isolated	NULL
immature	NULL
thymocytes	NULL
,	NULL
the	NULL
major	NULL
complex	NULL
was	NULL
the	NULL
transcriptionally	NULL
inactive	NULL
p50-p50	NULL
,	NULL
while	NULL
the	NULL
p50-p65	NULL
complex	NULL
was	NULL
hardly	NULL
visible	NULL
(	NULL
antibody	NULL
upshifting	NULL
confirmed	NULL
this	NULL
interpretation	NULL
[	NULL
data	NULL
not	NULL
shown	NULL
]	NULL
)	NULL
.	NULL

We	NULL
also	NULL
confirmed	NULL
that	NULL
TNF	NULL
maintained	NULL
p50-p65	NULL
A	NULL
Mature	NULL
CD4+CDS8-CD3+	NULL
J.	NULL
Virou	NULL
.	NULL

activity	NULL
in	NULL
the	NULL
mature	NULL
CD4*	NULL
CD8~	NULL
CD3+*	NULL
thymocytes	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
this	NULL
cytokine	NULL
can	NULL
induce	NULL
p50-p65	NULL
activity	NULL
also	NULL
in	NULL
the	NULL
immature	NULL
thymocytes	NULL
cultured	NULL
for	NULL
45	NULL
h	NULL
,	NULL
demonstrating	NULL
again	NULL
that	NULL
the	NULL
absence	NULL
of	NULL
p50-p65	NULL
complex	NULL
in	NULL
freshly	NULL
isolated	NULL
cells	NULL
was	NULL
not	NULL
associated	NULL
with	NULL
a	NULL
defect	NULL
in	NULL
responsiveness	NULL
to	NULL
this	NULL
cytokine	NULL
.	NULL

In	NULL
the	NULL
two	NULL
populations	NULL
(	NULL
mature	NULL
and	NULL
immature	NULL
)	NULL
,	NULL
IL-7	NULL
by	NULL
itself	NULL
does	NULL
not	NULL
induce	NULL
p50-p65	NULL
but	NULL
,	NULL
rather	NULL
,	NULL
is	NULL
a	NULL
cofactor	NULL
with	NULL
TNF	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
p50-p65	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Therefore	NULL
,	NULL
convergent	NULL
lines	NULL
of	NULL
evidence	NULL
indicate	NULL
that	NULL
HIV	NULL
replication	NULL
can	NULL
not	NULL
take	NULL
place	NULL
in	NULL
intermediate	NULL
thymocytes	NULL
because	NULL
of	NULL
the	NULL
absence	NULL
of	NULL
p50-p65	NULL
complex	NULL
,	NULL
essentially	NULL
due	NULL
to	NULL
the	NULL
impairment	NULL
of	NULL
TNF	NULL
production	NULL
during	NULL
the	NULL
interaction	NULL
with	NULL
TEC	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mature	NULL
thymocytes	NULL
fulfill	NULL
the	NULL
requirement	NULL
for	NULL
TNF	NULL
secretion	NULL
during	NULL
coculture	NULL
with	NULL
TEC	NULL
associated	NULL
with	NULL
an	NULL
IL-7	NULL
secretion	NULL
for	NULL
an	NULL
efficient	NULL
NF-kB-de-pendent	NULL
transcription	NULL
of	NULL
the	NULL
viral	NULL
genome	NULL
.	NULL

IL-7	NULL
sustains	NULL
expression	NULL
of	NULL
the	NULL
p75	NULL
TNF	NULL
receptor	NULL
.	NULL

The	NULL
role	NULL
of	NULL
IL-7	NULL
as	NULL
a	NULL
cofactor	NULL
of	NULL
TNF	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
was	NULL
further	NULL
investigated	NULL
in	NULL
the	NULL
mature	NULL
CD4*	NULL
CD8~	NULL
CD3	NULL
*	NULL
thymocytes	NULL
.	NULL

We	NULL
determined	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
two	NULL
TNF	NULL
receptors	NULL
,	NULL
p55	NULL
and	NULL
p75	NULL
(	NULL
12	NULL
)	NULL
,	NULL
by	NULL
immunostaining	NULL
and	NULL
flow	NULL
cytometry	NULL
in	NULL
mature	NULL
thymocytes	NULL
either	NULL
freshly	NULL
isolated	NULL
or	NULL
maintained	NULL
in	NULL
culture	NULL
for	NULL
4	NULL
days	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-7	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
p75	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
mature	NULL
thymocytes	NULL
just	NULL
after	NULL
their	NULL
isolation	NULL
.	NULL

However	NULL
,	NULL
p75	NULL
expression	NULL
was	NULL
not	NULL
maintained	NULL
in	NULL
culture	NULL
and	NULL
was	NULL
no	NULL
longer	NULL
detectable	NULL
at	NULL
4	NULL
days	NULL
unless	NULL
IL-7	NULL
was	NULL
added	NULL
to	NULL
the	NULL
culture	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
p55	NULL
expression	NULL
,	NULL
conversely	NULL
to	NULL
p75	NULL
,	NULL
persists	NULL
in	NULL
culture	NULL
and	NULL
IL-7	NULL
has	NULL
no	NULL
noticeable	NULL
effect	NULL
.	NULL

DISCUSSION	NULL
For	NULL
a	NULL
better	NULL
evaluation	NULL
of	NULL
the	NULL
consequences	NULL
of	NULL
HIV	NULL
infection	NULL
of	NULL
the	NULL
thymus	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
HIV	NULL
replication	NULL
was	NULL
favored	NULL
in	NULL
thymocytes	NULL
at	NULL
certain	NULL
stages	NULL
of	NULL
their	NULL
differentiation	NULL
.	NULL

Our	NULL
previous	NULL
in	NULL
vitro	NULL
studies	NULL
demonstrated	NULL
the	NULL
crucial	NULL
role	NULL
of	NULL
interaction	NULL
of	NULL
thymocytes	NULL
with	NULL
TEC	NULL
to	NULL
produce	NULL
a	NULL
high-level	NULL
virus	NULL
replication	NULL
.	NULL

We	NULL
pointed	NULL
out	NULL
the	NULL
role	NULL
of	NULL
this	NULL
interaction	NULL
in	NULL
creating	NULL
a	NULL
favorable	NULL
cytokine	NULL
microenvironment	NULL
that	NULL
was	NULL
able	NULL
to	NULL
activate	NULL
virus	NULL
replication	NULL
mainly	NULL
through	NULL
TNF	NULL
,	NULL
B	NULL
Immature	NULL
CD4~+CD§CD3	NULL
:	NULL
Freshly	NULL
isolated	NULL
45	NULL
hours	NULL
culture	NULL
Eliza	NULL
}	NULL
45	NULL
hours	NULL
culture	NULL
p	NULL
&	NULL
p	NULL
2	NULL
tibodi	NULL
inst	NULL
3	NULL
E	NULL
3	NULL
e	NULL
3	NULL
T	NULL
-l	NULL
an	NULL
ies	NULL
agains	NULL
G	NULL
2	NULL
G	NULL
0	NULL
A	NULL
é	NULL
'	NULL
AAs	NULL
é	NULL
3	NULL
E	NULL
&	NULL
on	NULL
I	NULL
;	NULL
E	NULL
€	NULL
%	NULL
$	NULL
os	NULL
n	NULL
i	NULL
S	NULL
ReIB	NULL
p65	NULL
p50	NULL
s	NULL
8	NULL
5	NULL
E	NULL
@	NULL
®	NULL
$	NULL
$	NULL
8	NULL
$	NULL
E	NULL
R2	NULL
R	NULL
p50-p65	NULL
-m	NULL
'	NULL
b	NULL
lee	NULL
id	NULL
ea	NULL
fe	NULL
d	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

The	NULL
p50-p65	NULL
complex	NULL
is	NULL
present	NULL
in	NULL
the	NULL
freshly	NULL
isolated	NULL
mature	NULL
CD4*	NULL
CD8~	NULL
CD3*	NULL
thymocytes	NULL
(	NULL
A	NULL
)	NULL
but	NULL
not	NULL
in	NULL
the	NULL
immature	NULL
CD4*	NULL
CD8~	NULL
CD3~	NULL
ones	NULL
(	NULL
B	NULL
)	NULL
.	NULL

TNF	NULL
and	NULL
IL-7	NULL
coinduce	NULL
this	NULL
activity	NULL
in	NULL
both	NULL
subsets	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Whole-cell	NULL
extracts	NULL
from	NULL
freshly	NULL
isolated	NULL
mature	NULL
CD4*	NULL
CD8~	NULL
CD3~	NULL
thymocytes	NULL
were	NULL
preincubated	NULL
cither	NULL
with	NULL
a	NULL
preimmune	NULL
serum	NULL
(	NULL
control	NULL
)	NULL
or	NULL
with	NULL
antibodies	NULL
against	NULL
RelB	NULL
,	NULL
p65	NULL
,	NULL
or	NULL
p50	NULL
before	NULL
incubation	NULL
with	NULL
a	NULL
*°P-labeled	NULL
oligonucleotide	NULL
representing	NULL
the	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat-derived	NULL
xB	NULL
motif	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
two	NULL
specific	NULL
bands	NULL
,	NULL
p50-p65	NULL
and	NULL
p50-p50	NULL
,	NULL
are	NULL
indicated	NULL
.	NULL

Mature	NULL
CD4	NULL
*	NULL
CD8~	NULL
CD3	NULL
``	NULL
thymocytes	NULL
were	NULL
also	NULL
cultured	NULL
for	NULL
45	NULL
h	NULL
either	NULL
unstimulated	NULL
(	NULL
control	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
TNF	NULL
,	NULL
IL-7	NULL
,	NULL
or	NULL
TNF	NULL
plus	NULL
IL-7	NULL
,	NULL
or	NULL
cocultured	NULL
with	NULL
TEC	NULL
as	NULL
indicated	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
from	NULL
these	NULL
various	NULL
samples	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
*°P-labeled	NULL
oligonucleotide	NULL
representing	NULL
the	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat-derived	NULL
B	NULL
motif	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Immature	NULL
CD4*	NULL
CD8~	NULL
CD3~	NULL
thymocytes	NULL
were	NULL
freshly	NULL
isolated	NULL
or	NULL
cultured	NULL
for	NULL
45	NULL
h	NULL
either	NULL
unstimulated	NULL
(	NULL
control	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
TNF	NULL
or	NULL
with	NULL
IL-7	NULL
or	NULL
with	NULL
TNF	NULL
plus	NULL
IL-7	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
from	NULL
these	NULL
various	NULL
samples	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
*°P-labeled	NULL
oligonucleotide	NULL
representing	NULL
the	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat-derived	NULL
xB	NULL
motif	NULL
.	NULL

This	NULL
experiment	NULL
is	NULL
representative	NULL
of	NULL
five	NULL
experiments	NULL
performed	NULL
on	NULL
five	NULL
different	NULL
thymuses	NULL
.	NULL

Vou	NULL
.	NULL

73	NULL
,	NULL
1999	NULL
HIV	NULL
REPLICATION	NULL
IN	NULL
CD4*	NULL
THYMOCYTES	NULL
7539	NULL
Day	NULL
0	NULL
Day	NULL
4	NULL
Without	NULL
IL-7	NULL
With	NULL
IL-7	NULL
E	NULL
pum	NULL
an	NULL
smns	NULL
g	NULL
ovencar	NULL
:	NULL
paver	NULL
A	NULL
TNF	NULL
R2	NULL
(	NULL
p75	NULL
)	NULL
B	NULL
TNF	NULL
R1	NULL
(	NULL
pSS	NULL
)	NULL
+A	NULL
_	NULL
a	NULL
-	NULL
in	NULL
-	NULL
198	NULL
a	NULL
00	NULL
100	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

IL-7	NULL
maintains	NULL
p75	NULL
TNF	NULL
receptor	NULL
expression	NULL
on	NULL
the	NULL
mature	NULL
CD4*	NULL
CD87	NULL
CD3~	NULL
thymocytes	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
two	NULL
TNF	NULL
receptors	NULL
,	NULL
p75	NULL
(	NULL
A	NULL
)	NULL
and	NULL
p55	NULL
(	NULL
B	NULL
)	NULL
,	NULL
was	NULL
determined	NULL
by	NULL
flow	NULL
cytometry	NULL
on	NULL
the	NULL
mature	NULL
CD4*	NULL
CD8~	NULL
CD3*	NULL
thymocytes	NULL
,	NULL
either	NULL
freshly	NULL
isolated	NULL
or	NULL
cultured	NULL
for	NULL
4	NULL
days	NULL
without	NULL
IL-7	NULL
or	NULL
with	NULL
IL-7	NULL
as	NULL
indicated	NULL
.	NULL

Thymocytes	NULL
were	NULL
stained	NULL
with	NULL
FITC	NULL
anti-p75	NULL
,	NULL
FITC	NULL
anti-p55	NULL
,	NULL
or	NULL
FITC	NULL
anti-IgG	NULL
control	NULL
.	NULL

p75	NULL
and	NULL
p55	NULL
fluorescence	NULL
histograms	NULL
are	NULL
shown	NULL
(	NULL
solid	NULL
line	NULL
)	NULL
in	NULL
comparison	NULL
with	NULL
those	NULL
obtained	NULL
with	NULL
the	NULL
isotype-matched	NULL
controls	NULL
(	NULL
broken	NULL
line	NULL
)	NULL
.	NULL

This	NULL
experiment	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
performed	NULL
on	NULL
three	NULL
different	NULL
thymuses	NULL
.	NULL

IL-1	NULL
,	NULL
IL-6	NULL
(	NULL
45	NULL
)	NULL
,	NULL
and	NULL
IL-7	NULL
(	NULL
14	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
protecting	NULL
thymocytes	NULL
against	NULL
apoptosis	NULL
through	NULL
GM-CSF	NULL
(	NULL
4	NULL
,	NULL
25	NULL
)	NULL
and	NULL
IL-7	NULL
(	NULL
1	NULL
,	NULL
22	NULL
)	NULL
.	NULL

These	NULL
previous	NULL
data	NULL
have	NULL
been	NULL
obtained	NULL
by	NULL
infecting	NULL
the	NULL
total	NULL
population	NULL
of	NULL
thymocytes	NULL
with	NULL
various	NULL
primary	NULL
isolates	NULL
or	NULL
laboratory	NULL
strains	NULL
(	NULL
14	NULL
,	NULL
45	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
identified	NULL
,	NULL
within	NULL
this	NULL
total	NULL
population	NULL
,	NULL
the	NULL
subpopulations	NULL
of	NULL
thymocytes	NULL
in	NULL
which	NULL
this	NULL
high-level	NULL
replication	NULL
readily	NULL
occurs	NULL
with	NULL
the	NULL
HIV-15	NULL
Lap	NULL
primary	NULL
isolate	NULL
.	NULL

We	NULL
obtained	NULL
the	NULL
same	NULL
results	NULL
with	NULL
the	NULL
molecular	NULL
clone	NULL
NL-4-3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
specified	NULL
the	NULL
characteristics	NULL
of	NULL
these	NULL
cells	NULL
which	NULL
permit	NULL
such	NULL
a	NULL
virus	NULL
production	NULL
.	NULL

The	NULL
first	NULL
step	NULL
of	NULL
this	NULL
work	NULL
consisted	NULL
of	NULL
enriching	NULL
the	NULL
CD4	NULL
*	NULL
subpopulations	NULL
susceptible	NULL
to	NULL
HIV	NULL
infection	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
various	NULL
CD4	NULL
*	NULL
populations	NULL
were	NULL
isolated	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
their	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
CD4	NULL
but	NULL
also	NULL
of	NULL
CD3	NULL
,	NULL
a	NULL
criterion	NULL
of	NULL
cell	NULL
maturity	NULL
.	NULL

We	NULL
developed	NULL
methods	NULL
to	NULL
enrich	NULL
these	NULL
different	NULL
subpopulations	NULL
,	NULL
avoiding	NULL
nonspecific	NULL
activation	NULL
.	NULL

In	NULL
most	NULL
cases	NULL
,	NULL
except	NULL
for	NULL
the	NULL
DP	NULL
thymocytes	NULL
,	NULL
negative	NULL
selection	NULL
was	NULL
used	NULL
.	NULL

However	NULL
,	NULL
no	NULL
activation	NULL
subsequent	NULL
to	NULL
CD4	NULL
and	NULL
CD8	NULL
cell	NULL
sorting	NULL
of	NULL
these	NULL
cells	NULL
was	NULL
observed	NULL
since	NULL
no	NULL
virus	NULL
replication	NULL
was	NULL
detectable	NULL
.	NULL

Figure	NULL
1	NULL
indicates	NULL
the	NULL
rate	NULL
of	NULL
enrichment	NULL
of	NULL
these	NULL
subpopulations	NULL
and	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
different	NULL
markers	NULL
within	NULL
each	NULL
subset	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
mature	NULL
CD4*	NULL
CD8~	NULL
CD3	NULL
*	NULL
cells	NULL
obtained	NULL
by	NULL
negative	NULL
selection	NULL
with	NULL
CD8	NULL
,	NULL
CD10	NULL
and	NULL
CD34	NULL
antibodies	NULL
led	NULL
to	NULL
a	NULL
subset	NULL
of	NULL
CD8~	NULL
thymocytes	NULL
that	NULL
have	NULL
undergone	NULL
positive	NULL
selection	NULL
,	NULL
as	NULL
also	NULL
indicated	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
CD69	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
associated	NULL
with	NULL
a	NULL
strong	NULL
expression	NULL
of	NULL
CD3	NULL
(	NULL
28	NULL
,	NULL
54	NULL
)	NULL
.	NULL

A	NULL
small	NULL
part	NULL
of	NULL
this	NULL
population	NULL
was	NULL
determined	NULL
to	NULL
express	NULL
CD4	NULL
at	NULL
a	NULL
low	NULL
level	NULL
.	NULL

These	NULL
cells	NULL
probably	NULL
represent	NULL
a	NULL
mature	NULL
population	NULL
that	NULL
has	NULL
undergone	NULL
positive	NULL
selection	NULL
and	NULL
downregulated	NULL
both	NULL
CD4	NULL
and	NULL
CD8	NULL
before	NULL
differentiation	NULL
to	NULL
single-positive	NULL
CD4*	NULL
or	NULL
CD8	NULL
*	NULL
cells	NULL
(	NULL
13	NULL
,	NULL
58	NULL
)	NULL
,	NULL
or	NULL
they	NULL
might	NULL
also	NULL
represent	NULL
thymocytes	NULL
expressing	NULL
the	NULL
y8	NULL
T-cell	NULL
receptor	NULL
described	NULL
that	NULL
do	NULL
not	NULL
express	NULL
detectable	NULL
levels	NULL
of	NULL
CD4	NULL
(	NULL
38	NULL
)	NULL
.	NULL

We	NULL
first	NULL
show	NULL
that	NULL
the	NULL
population	NULL
of	NULL
mature	NULL
CD4~*	NULL
CD8~	NULL
CD3	NULL
*	NULL
thymocytes	NULL
is	NULL
the	NULL
only	NULL
one	NULL
able	NULL
to	NULL
exhibit	NULL
a	NULL
high-level	NULL
virus	NULL
replication	NULL
when	NULL
cocultured	NULL
with	NULL
TEC	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

HIV	NULL
replication	NULL
in	NULL
the	NULL
mature	NULL
subpopulation	NULL
was	NULL
about	NULL
5-	NULL
to	NULL
20-fold	NULL
higher	NULL
than	NULL
that	NULL
observed	NULL
in	NULL
total	NULL
thymocytes	NULL
,	NULL
whereas	NULL
this	NULL
subset	NULL
represents	NULL
1/20	NULL
of	NULL
the	NULL
total	NULL
thymocytes	NULL
.	NULL

Since	NULL
infection	NULL
progresses	NULL
in	NULL
an	NULL
exponential	NULL
manner	NULL
,	NULL
we	NULL
might	NULL
have	NULL
expected	NULL
a	NULL
more	NULL
marked	NULL
difference	NULL
.	NULL

This	NULL
result	NULL
may	NULL
also	NULL
suggest	NULL
that	NULL
within	NULL
the	NULL
total	NULL
thymocytes	NULL
,	NULL
the	NULL
other	NULL
subpopulations	NULL
facilitated	NULL
HIV	NULL
replication	NULL
within	NULL
the	NULL
mature	NULL
subset	NULL
.	NULL

No	NULL
replication	NULL
was	NULL
detectable	NULL
in	NULL
the	NULL
other	NULL
CD4*	NULL
thymocytes	NULL
including	NULL
the	NULL
intermediate	NULL
CD4*	NULL
CD8~	NULL
CD3~	NULL
and	NULL
the	NULL
DP	NULL
CD4*	NULL
CD8*	NULL
CD3*	NULL
subsets	NULL
cocultured	NULL
with	NULL
TEC	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
be	NULL
infected	NULL
was	NULL
not	NULL
in	NULL
doubt	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
us	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
others	NULL
(	NULL
49	NULL
,	NULL
55	NULL
)	NULL
by	NULL
PCR	NULL
analysis	NULL
of	NULL
the	NULL
proviral	NULL
genome	NULL
or	NULL
by	NULL
expression	NULL
of	NULL
murine	NULL
genes	NULL
inserted	NULL
into	NULL
the	NULL
nef	NULL
(	NULL
30	NULL
)	NULL
or	NULL
vpr	NULL
(	NULL
26	NULL
)	NULL
region	NULL
of	NULL
HIV-1y	NULL
;	NULL
,	NULL
,	NULL
,	NULL
provirus	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
some	NULL
replication	NULL
might	NULL
occur	NULL
in	NULL
the	NULL
other	NULL
subsets	NULL
but	NULL
at	NULL
very	NULL
low	NULL
levels	NULL
,	NULL
undetectable	NULL
by	NULL
p24®*	NULL
determination	NULL
in	NULL
culture	NULL
supernatants	NULL
.	NULL

In	NULL
the	NULL
TN	NULL
and	NULL
DP	NULL
subsets	NULL
,	NULL
this	NULL
absence	NULL
of	NULL
detectable	NULL
replication	NULL
is	NULL
associated	NULL
with	NULL
unresponsiveness	NULL
to	NULL
the	NULL
cytokines	NULL
required	NULL
for	NULL
a	NULL
high-level	NULL
replication	NULL
(	NULL
TNF	NULL
,	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
IL-7	NULL
,	NULL
and	NULL
GM-CSF	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
intermediate	NULL
subset	NULL
does	NULL
not	NULL
exhibit	NULL
a	NULL
defect	NULL
in	NULL
responsiveness	NULL
to	NULL
one	NULL
or	NULL
more	NULL
of	NULL
these	NULL
cytokines	NULL
,	NULL
since	NULL
these	NULL
cells	NULL
support	NULL
a	NULL
high	NULL
level	NULL
of	NULL
replication	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
these	NULL
cytokines	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

We	NULL
demonstrated	NULL
that	NULL
IL-7	NULL
and	NULL
TNF	NULL
are	NULL
both	NULL
required	NULL
to	NULL
support	NULL
HIV	NULL
replication	NULL
in	NULL
both	NULL
the	NULL
mature	NULL
and	NULL
intermediate	NULL
subsets	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
requirement	NULL
for	NULL
TNF	NULL
and	NULL
IL-7	NULL
,	NULL
a	NULL
differential	NULL
role	NULL
of	NULL
GM-CSF	NULL
was	NULL
observed	NULL
.	NULL

This	NULL
cytokine	NULL
was	NULL
an	NULL
additional	NULL
important	NULL
factor	NULL
only	NULL
in	NULL
the	NULL
immature	NULL
subset	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
GM-CSF	NULL
observed	NULL
in	NULL
the	NULL
total	NULL
population	NULL
of	NULL
thymocytes	NULL
reflects	NULL
its	NULL
ability	NULL
to	NULL
support	NULL
viral	NULL
replication	NULL
essentially	NULL
in	NULL
7540	NULL
CHENE	NULL
ET	NULL
AL	NULL
.	NULL

the	NULL
intermediate	NULL
subpopulation	NULL
.	NULL

It	NULL
is	NULL
very	NULL
likely	NULL
that	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TNF	NULL
added	NULL
to	NULL
the	NULL
culture	NULL
,	NULL
the	NULL
synergistic	NULL
role	NULL
of	NULL
IL-1	NULL
is	NULL
hardly	NULL
visible	NULL
,	NULL
since	NULL
both	NULL
cytokines	NULL
act	NULL
on	NULL
NF-KB	NULL
activation	NULL
and	NULL
since	NULL
TNF	NULL
signaling	NULL
has	NULL
the	NULL
major	NULL
effect	NULL
(	NULL
14	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
IL-6	NULL
on	NULL
HIV	NULL
replication	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
mature	NULL
population	NULL
.	NULL

This	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
this	NULL
cytokine	NULL
was	NULL
shown	NULL
to	NULL
specifically	NULL
induce	NULL
the	NULL
proliferation	NULL
of	NULL
this	NULL
thymocyte	NULL
subset	NULL
(	NULL
50	NULL
)	NULL
.	NULL

The	NULL
requirement	NULL
for	NULL
IL-7	NULL
might	NULL
explain	NULL
the	NULL
absence	NULL
of	NULL
viral	NULL
production	NULL
in	NULL
the	NULL
DP	NULL
cells	NULL
,	NULL
since	NULL
most	NULL
of	NULL
them	NULL
do	NULL
not	NULL
express	NULL
the	NULL
IL-7	NULL
receptor	NULL
(	NULL
51	NULL
)	NULL
.	NULL

However	NULL
,	NULL
according	NULL
to	NULL
the	NULL
murine	NULL
model	NULL
,	NULL
a	NULL
small	NULL
fraction	NULL
of	NULL
the	NULL
DP	NULL
cells	NULL
(	NULL
around	NULL
5	NULL
%	NULL
)	NULL
which	NULL
have	NULL
undergone	NULL
positive	NULL
selection	NULL
have	NULL
acquired	NULL
this	NULL
receptor	NULL
.	NULL

We	NULL
can	NULL
not	NULL
exclude	NULL
replication	NULL
in	NULL
this	NULL
small	NULL
fraction	NULL
of	NULL
DP	NULL
cells	NULL
,	NULL
which	NULL
might	NULL
be	NULL
masked	NULL
by	NULL
the	NULL
high	NULL
rate	NULL
of	NULL
apoptosis	NULL
of	NULL
the	NULL
remaining	NULL
95	NULL
%	NULL
of	NULL
the	NULL
DP	NULL
cells	NULL
which	NULL
are	NULL
not	NULL
protected	NULL
by	NULL
the	NULL
antiapoptotic	NULL
effect	NULL
of	NULL
IL-7	NULL
in	NULL
culture	NULL
.	NULL

Response	NULL
to	NULL
TNF	NULL
might	NULL
not	NULL
also	NULL
be	NULL
efficient	NULL
in	NULL
this	NULL
set	NULL
of	NULL
DP	NULL
cells	NULL
,	NULL
since	NULL
TNF	NULL
receptors	NULL
are	NULL
present	NULL
on	NULL
only	NULL
3	NULL
%	NULL
of	NULL
the	NULL
total	NULL
population	NULL
of	NULL
thymocytes	NULL
46	NULL
)	NULL
.	NULL

(	NULL
V	NULL
)	NULL
Ve	NULL
previously	NULL
demonstrated	NULL
with	NULL
the	NULL
total	NULL
population	NULL
of	NULL
thymocytes	NULL
(	NULL
14	NULL
,	NULL
45	NULL
)	NULL
that	NULL
TNF	NULL
and	NULL
IL-7	NULL
act	NULL
synergistically	NULL
to	NULL
enhance	NULL
HIV	NULL
transcription	NULL
through	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
fac-tors	NULL
,	NULL
with	NULL
p50-p65	NULL
being	NULL
the	NULL
prevalent	NULL
complex	NULL
observed	NULL
.	NULL

We	NULL
demonstrate	NULL
here	NULL
that	NULL
the	NULL
p50-p65	NULL
activity	NULL
observed	NULL
in	NULL
the	NULL
total	NULL
population	NULL
is	NULL
clearly	NULL
located	NULL
in	NULL
the	NULL
freshly	NULL
isolated	NULL
mature	NULL
thymocytes	NULL
and	NULL
is	NULL
maintained	NULL
either	NULL
by	NULL
coculture	NULL
with	NULL
TEC	NULL
or	NULL
by	NULL
the	NULL
synergistic	NULL
effect	NULL
of	NULL
TNF	NULL
and	NULL
IL-7	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

The	NULL
major	NULL
role	NULL
of	NULL
TNF	NULL
in	NULL
HIV	NULL
replication	NULL
in	NULL
thymocytes	NULL
was	NULL
further	NULL
confirmed	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
only	NULL
barrier	NULL
to	NULL
virus	NULL
production	NULL
in	NULL
intermediate	NULL
thymocytes	NULL
was	NULL
a	NULL
defect	NULL
in	NULL
TNF	NULL
production	NULL
during	NULL
their	NULL
interaction	NULL
with	NULL
TEC	NULL
.	NULL

Indeed	NULL
,	NULL
addition	NULL
of	NULL
exogenous	NULL
TNF	NULL
to	NULL
the	NULL
coculture	NULL
was	NULL
sufficient	NULL
to	NULL
induce	NULL
replication	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
relevance	NULL
of	NULL
the	NULL
absence	NULL
of	NULL
an	NULL
efficient	NULL
stimulation	NULL
by	NULL
TNF	NULL
in	NULL
the	NULL
microenvironment	NULL
of	NULL
the	NULL
intermediate	NULL
thymocytes	NULL
was	NULL
supported	NULL
in	NULL
vivo	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
these	NULL
thymocytes	NULL
,	NULL
freshly	NULL
isolated	NULL
,	NULL
are	NULL
devoid	NULL
of	NULL
nuclear	NULL
p50-p65	NULL
activ-ity	NULL
.	NULL

The	NULL
p50-p50	NULL
complex	NULL
was	NULL
observed	NULL
,	NULL
but	NULL
this	NULL
complex	NULL
is	NULL
transcriptionally	NULL
inactive	NULL
(	NULL
19	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

When	NULL
added	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
of	NULL
these	NULL
thymocytes	NULL
,	NULL
TNF	NULL
induces	NULL
the	NULL
activation	NULL
of	NULL
p50-p65	NULL
,	NULL
suggesting	NULL
again	NULL
the	NULL
lack	NULL
of	NULL
TNF	NULL
in	NULL
the	NULL
microenvironment	NULL
.	NULL

The	NULL
role	NULL
of	NULL
IL-7	NULL
as	NULL
a	NULL
cofactor	NULL
with	NULL
TNF	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
further	NULL
investigated	NULL
in	NULL
the	NULL
mature	NULL
thymocytes	NULL
.	NULL

We	NULL
showed	NULL
that	NULL
TNF	NULL
receptors	NULL
p55	NULL
and	NULL
p75	NULL
(	NULL
12	NULL
)	NULL
were	NULL
both	NULL
expressed	NULL
when	NULL
cells	NULL
were	NULL
freshly	NULL
isolated	NULL
from	NULL
their	NULL
thymic	NULL
environment	NULL
.	NULL

Culture	NULL
of	NULL
these	NULL
cells	NULL
led	NULL
to	NULL
a	NULL
decrease	NULL
of	NULL
p75	NULL
expression	NULL
,	NULL
whereas	NULL
p55	NULL
expression	NULL
was	NULL
much	NULL
more	NULL
stable	NULL
.	NULL

However	NULL
,	NULL
IL-7	NULL
was	NULL
able	NULL
to	NULL
maintain	NULL
p75	NULL
expression	NULL
in	NULL
culture	NULL
but	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
p55	NULL
expression	NULL
.	NULL

It	NULL
is	NULL
worth	NULL
noting	NULL
that	NULL
IL-7	NULL
,	NULL
known	NULL
for	NULL
its	NULL
antiapoptotic	NULL
role	NULL
,	NULL
favors	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
p75	NULL
receptor	NULL
,	NULL
which	NULL
leads	NULL
exclusively	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
,	NULL
and	NULL
not	NULL
that	NULL
of	NULL
the	NULL
p55	NULL
receptor	NULL
,	NULL
which	NULL
also	NULL
leads	NULL
to	NULL
an	NULL
apoptotic	NULL
pathway	NULL
.	NULL

This	NULL
increase	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
by	NULL
itself	NULL
,	NULL
might	NULL
serve	NULL
to	NULL
protect	NULL
against	NULL
apoptosis	NULL
induced	NULL
by	NULL
TNF	NULL
signaling	NULL
through	NULL
p55	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Since	NULL
p55	NULL
expression	NULL
is	NULL
constitutively	NULL
stable	NULL
,	NULL
this	NULL
receptor	NULL
might	NULL
be	NULL
sufficient	NULL
to	NULL
induce	NULL
the	NULL
NF-kB	NULL
activation	NULL
necessary	NULL
for	NULL
HIV	NULL
replication	NULL
even	NULL
in	NULL
absence	NULL
of	NULL
IL-7	NULL
,	NULL
but	NULL
the	NULL
higher	NULL
rate	NULL
of	NULL
cell	NULL
death	NULL
(	NULL
observed	NULL
in	NULL
the	NULL
culture	NULL
in	NULL
absence	NULL
of	NULL
IL-7	NULL
)	NULL
might	NULL
impair	NULL
this	NULL
process	NULL
.	NULL

This	NULL
interpretation	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
data	NULL
in	NULL
the	NULL
literature	NULL
showing	NULL
that	NULL
only	NULL
agonists	NULL
of	NULL
the	NULL
p75	NULL
receptor	NULL
lead	NULL
to	NULL
thymocyte	NULL
activation	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
their	NULL
proliferation	NULL
,	NULL
whereas	NULL
agonists	NULL
of	NULL
p55	NULL
receptor	NULL
mediate	NULL
cytotoxicity	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Since	NULL
GM-CSF	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
HIV	NULL
replication	NULL
in	NULL
the	NULL
immature	NULL
population	NULL
,	NULL
we	NULL
also	NULL
tested	NULL
its	NULL
effect	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
two	NULL
TNF	NULL
receptors	NULL
.	NULL

However	NULL
,	NULL
J.	NULL
Virou	NULL
.	NULL

since	NULL
the	NULL
viability	NULL
of	NULL
the	NULL
immature	NULL
thymocytes	NULL
is	NULL
highly	NULL
dependent	NULL
on	NULL
IL-7	NULL
,	NULL
we	NULL
tested	NULL
GM-CSF	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-7	NULL
and	NULL
found	NULL
that	NULL
the	NULL
levels	NULL
of	NULL
the	NULL
two	NULL
TNF	NULL
receptors	NULL
were	NULL
identical	NULL
to	NULL
those	NULL
observed	NULL
with	NULL
IL-7	NULL
alone	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
led	NULL
us	NULL
to	NULL
establish	NULL
the	NULL
following	NULL
model	NULL
for	NULL
the	NULL
dynamics	NULL
of	NULL
HIV	NULL
replication	NULL
in	NULL
the	NULL
thymus	NULL
.	NULL

Our	NULL
study	NULL
argues	NULL
for	NULL
a	NULL
preferential	NULL
replication	NULL
within	NULL
the	NULL
mature	NULL
CD4*	NULL
CD8~	NULL
CD3	NULL
*	NULL
thymocytes	NULL
as	NULL
a	NULL
result	NULL
of	NULL
their	NULL
interaction	NULL
with	NULL
TEC	NULL
by	NULL
a	NULL
process	NULL
involving	NULL
TNF	NULL
and	NULL
IL-7	NULL
secretion	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
a	NULL
high	NULL
viral	NULL
load	NULL
in	NULL
this	NULL
population	NULL
might	NULL
be	NULL
responsible	NULL
in	NULL
vivo	NULL
for	NULL
an	NULL
increase	NULL
of	NULL
the	NULL
peripheral	NULL
viral	NULL
load	NULL
,	NULL
explaining	NULL
a	NULL
rapid	NULL
progression	NULL
toward	NULL
AIDS	NULL
.	NULL

We	NULL
can	NULL
also	NULL
speculate	NULL
that	NULL
the	NULL
intermediate	NULL
thymocytes	NULL
may	NULL
contribute	NULL
to	NULL
viral	NULL
spreading	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TNF	NULL
,	NULL
secreted	NULL
in	NULL
their	NULL
mi-croenvironment	NULL
,	NULL
by	NULL
inflammatory	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
infection	NULL
of	NULL
the	NULL
mature	NULL
population	NULL
.	NULL

This	NULL
sequence	NULL
of	NULL
events	NULL
was	NULL
actually	NULL
observed	NULL
in	NULL
the	NULL
thymus	NULL
of	NULL
juvenile	NULL
cats	NULL
infected	NULL
by	NULL
feline	NULL
immunodeficiency	NULL
virus	NULL
:	NULL
a	NULL
high	NULL
level	NULL
of	NULL
virus	NULL
was	NULL
observed	NULL
within	NULL
mature	NULL
thymocytes	NULL
early	NULL
postinfection	NULL
,	NULL
whereas	NULL
infection	NULL
of	NULL
the	NULL
immature	NULL
thymocytes	NULL
was	NULL
seen	NULL
later	NULL
and	NULL
was	NULL
associated	NULL
with	NULL
the	NULL
inflammatory	NULL
response	NULL
and	NULL
cortical	NULL
atrophy	NULL
(	NULL
62	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
infection	NULL
of	NULL
this	NULL
immature	NULL
population	NULL
is	NULL
upregulated	NULL
by	NULL
GM-CSF	NULL
.	NULL

This	NULL
cytokine	NULL
might	NULL
act	NULL
by	NULL
increasing	NULL
thymocyte	NULL
viability	NULL
(	NULL
23	NULL
,	NULL
29	NULL
)	NULL
or	NULL
,	NULL
as	NULL
suggested	NULL
previously	NULL
(	NULL
21	NULL
)	NULL
,	NULL
by	NULL
increasing	NULL
IL-7	NULL
receptor	NULL
expression	NULL
on	NULL
the	NULL
thymocyte	NULL
surface	NULL
(	NULL
21	NULL
)	NULL
.	NULL

We	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
GM-CSF	NULL
with	NULL
TNF	NULL
favors	NULL
the	NULL
differentiation	NULL
of	NULL
immature	NULL
CD34*	NULL
thymocytes	NULL
into	NULL
dendritic	NULL
cells	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
addition	NULL
of	NULL
GM-CSF	NULL
to	NULL
immature	NULL
CD4*	NULL
CD8~	NULL
CD3~	NULL
cells	NULL
cultured	NULL
with	NULL
IL-7	NULL
and	NULL
TNF	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
cells	NULL
with	NULL
dendritic	NULL
morphology	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Dendritic	NULL
cells	NULL
were	NULL
shown	NULL
to	NULL
strongly	NULL
enhance	NULL
HIV	NULL
replication	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
43	NULL
)	NULL
,	NULL
and	NULL
thymic	NULL
dendritic	NULL
cells	NULL
were	NULL
also	NULL
found	NULL
to	NULL
support	NULL
HIV	NULL
replication	NULL
(	NULL
8	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
dendritic	NULL
differentiation	NULL
and	NULL
infection	NULL
,	NULL
in	NULL
the	NULL
immature	NULL
compartment	NULL
,	NULL
also	NULL
contributes	NULL
to	NULL
the	NULL
inflammatory	NULL
response	NULL
.	NULL

Such	NULL
an	NULL
inflammatory	NULL
response	NULL
,	NULL
by	NULL
favoring	NULL
virus	NULL
spreading	NULL
,	NULL
might	NULL
lead	NULL
to	NULL
direct	NULL
destruction	NULL
of	NULL
these	NULL
cells	NULL
(	NULL
49	NULL
)	NULL
and	NULL
disruption	NULL
of	NULL
the	NULL
cortical	NULL
microenvironment	NULL
and	NULL
may	NULL
contribute	NULL
to	NULL
an	NULL
irreversible	NULL
adverse	NULL
effect	NULL
on	NULL
T-cell	NULL
regeneration	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
L.	NULL
Chéne	NULL
and	NULL
M.-T.	NULL
Nugeyre	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL

We	NULL
are	NULL
very	NULL
grateful	NULL
to	NULL
Sonia	NULL
Berrih-Aknin	NULL
and	NULL
to	NULL
Claude	NULL
Planché	NULL
(	NULL
Hospital	NULL
Marie-Lannelongue	NULL
,	NULL
Le	NULL
Plessis-Robinson	NULL
,	NULL
France	NULL
)	NULL
for	NULL
providing	NULL
us	NULL
with	NULL
thymuses	NULL
from	NULL
infants	NULL
undergoing	NULL
cardiac	NULL
surgery	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Sonia	NULL
Berrih-Aknin	NULL
for	NULL
helpful	NULL
discussions	NULL
.	NULL

We	NULL
thank	NULL
R.	NULL
H.	NULL
Bassin	NULL
for	NULL
careful	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Agence	NULL
Nationale	NULL
pour	NULL
la	NULL
Recherche	NULL
sur	NULL
le	NULL
SIDA	NULL
(	NULL
ANRS	NULL
)	NULL
.	NULL

L.	NULL
Chéne	NULL
was	NULL
a	NULL
fellow	NULL
of	NULL
the	NULL
French	NULL
Ministry	NULL
of	NULL
Education	NULL
and	NULL
Research	NULL
(	NULL
MENESR	NULL
)	NULL
.	NULL

E.	NULL
Guillemard	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
SIDACTION	NULL
fellowship	NULL
from	NULL
Fondation	NULL
pour	NULL
la	NULL
Recherche	NULL
Médicale	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Akashi	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Kondo	NULL
,	NULL
U.	NULL
yon	NULL
Freeden-Jeffry	NULL
,	NULL
R.	NULL
Murray	NULL
,	NULL
and	NULL
I.	NULL
L.	NULL
Weiss-man	NULL
.	NULL

1997	NULL
.	NULL

Bcl-2	NULL
rescues	NULL
T	NULL
lymphopoiesis	NULL
in	NULL
interleukin-7	NULL
receptor-defficient	NULL
mice	NULL
.	NULL

Cell	NULL
89:1033-1041	NULL
.	NULL

2	NULL
.	NULL

Aldrovandi	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
G.	NULL
Feuer	NULL
,	NULL
L.	NULL
Gao	NULL
,	NULL
B.	NULL
Jamieson	NULL
,	NULL
M.	NULL
Kristeva	NULL
,	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Zack	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
SCID-hu	NULL
mouse	NULL
as	NULL
a	NULL
model	NULL
for	NULL
HIV-1	NULL
infection	NULL
.	NULL

Nature	NULL
363:732-736	NULL
.	NULL

3	NULL
.	NULL

Autran	NULL
,	NULL
B.	NULL
,	NULL
G.	NULL
Carcelain	NULL
,	NULL
T.	NULL
S.	NULL
Li	NULL
,	NULL
C.	NULL
Blanc	NULL
,	NULL
D.	NULL
Mathez	NULL
,	NULL
R.	NULL
Tubiana	NULL
,	NULL
C.	NULL
Katlama	NULL
,	NULL
P.	NULL
Debre	NULL
,	NULL
and	NULL
J.	NULL
Leibowitch	NULL
.	NULL

1997	NULL
.	NULL

Positive	NULL
effects	NULL
of	NULL
combined	NULL
antiretroviral	NULL
therapy	NULL
on	NULL
CD4+	NULL
T	NULL
cell	NULL
homeostasis	NULL
and	NULL
function	NULL
in	NULL
advanced	NULL
HIV	NULL
disease	NULL
.	NULL

Science	NULL
277:112-116	NULL
.	NULL

4	NULL
.	NULL

Bach	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Brashler	NULL
.	NULL

1995	NULL
.	NULL

Evidence	NULL
that	NULL
granulocyte/macro-phage-colony-stimulating	NULL
factor	NULL
and	NULL
interferon-gamma	NULL
maintain	NULL
the	NULL
viability	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
in	NULL
part	NULL
by	NULL
their	NULL
suppression	NULL
of	NULL
IL-10	NULL
production	NULL
.	NULL

Int	NULL
.	NULL

Arch	NULL
.	NULL

Allergy	NULL
Immunol	NULL
.	NULL

107:90-92	NULL
.	NULL

5	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
1996	NULL
.	NULL

The	NULL
NF-kappa	NULL
B	NULL
and	NULL
I	NULL
kappa	NULL
B	NULL
proteins	NULL
:	NULL
new	NULL
discov-	NULL
voL	NULL
.	NULL

73	NULL
,	NULL
1999	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29.	NULL
cries	NULL
and	NULL
insights	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:649-683.	NULL
.	NULL

Barré-Sinoussi	NULL
,	NULL
F.	NULL
,	NULL
J.-C.	NULL
Chermann	NULL
,	NULL
F.	NULL
Rey	NULL
,	NULL
M.-T.	NULL
Nugeyre	NULL
,	NULL
S.	NULL
Chamaret	NULL
,	NULL
C.	NULL
Axler-Blin	NULL
,	NULL
F.	NULL
Vezinet-Brun	NULL
,	NULL
C.	NULL
Rouzioux	NULL
,	NULL
W.	NULL
Rozenbaum	NULL
,	NULL
and	NULL
L.	NULL
Montag-nier	NULL
.	NULL

1983	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
T	NULL
lymphotropic	NULL
retrovirus	NULL
from	NULL
a	NULL
patient	NULL
at	NULL
risk	NULL
for	NULL
acquired	NULL
immune	NULL
deficiency	NULL
syndrome	NULL
(	NULL
AIDS	NULL
)	NULL
.	NULL

Science	NULL
220:868-870.	NULL
.	NULL

Baskin	NULL
,	NULL
G.	NULL
B.	NULL
,	NULL
M.	NULL
Murphey-Corb	NULL
,	NULL
L.	NULL
N.	NULL
Martin	NULL
,	NULL
B.	NULL
Davison-Fairburn	NULL
,	NULL
F.-S.	NULL
Hu	NULL
,	NULL
and	NULL
D.	NULL
Kuebler	NULL
.	NULL

1991	NULL
.	NULL

Thymus	NULL
in	NULL
simian	NULL
immunodeficiency	NULL
virus-in-fected	NULL
rhesus	NULL
monkeys	NULL
.	NULL

Lab	NULL
.	NULL

Investig	NULL
.	NULL

65:400-407.	NULL
.	NULL

Beaulieu	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
Kessous	NULL
,	NULL
D.	NULL
Landry	NULL
,	NULL
S.	NULL
Montplaisir	NULL
,	NULL
D.	NULL
Bergeron	NULL
,	NULL
and	NULL
E.	NULL
A.	NULL
Cohen	NULL
.	NULL

1996	NULL
.	NULL

In	NULL
vitro	NULL
characterization	NULL
of	NULL
purified	NULL
human	NULL
thymic	NULL
dendritic	NULL
cells	NULL
infected	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

Virology	NULL
222:214-226.	NULL
.	NULL

Berkowitz	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
K.	NULL
P.	NULL
Bekerman	NULL
,	NULL
T.	NULL
J.	NULL
Schall	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
McCune	NULL
.	NULL

1998	NULL
.	NULL

CXCR4	NULL
and	NULL
CCR5	NULL
expression	NULL
delineates	NULL
target	NULL
for	NULL
HIV-1	NULL
disruption	NULL
of	NULL
T	NULL
cell	NULL
differentiation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:3702-3710	NULL
.	NULL

Bonyhadi	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
L.	NULL
Rabin	NULL
,	NULL
S.	NULL
Salimi	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

Brown	NULL
,	NULL
J.	NULL
Kosek	NULL
,	NULL
J.	NULL
M.	NULL
McCune	NULL
,	NULL
and	NULL
H.	NULL
Kaneshima	NULL
.	NULL

1993	NULL
.	NULL

HIV	NULL
induces	NULL
thymus	NULL
depletion	NULL
in	NULL
vivo	NULL
.	NULL

Nature	NULL
363:728-732	NULL
.	NULL

Braun	NULL
,	NULL
J.	NULL
,	NULL
H.	NULL
Valentin	NULL
,	NULL
M.	NULL
'T	NULL
.	NULL

Nugeyre	NULL
,	NULL
H.	NULL
Ohayon	NULL
,	NULL
P.	NULL
Gounon	NULL
,	NULL
and	NULL
F.	NULL
Barré-Sinoussi	NULL
.	NULL

1996	NULL
.	NULL

Productive	NULL
and	NULL
persistent	NULL
infection	NULL
of	NULL
human	NULL
thymic	NULL
epithelial	NULL
cells	NULL
in	NULL
vitro	NULL
with	NULL
HIV-1	NULL
.	NULL

Virology	NULL
225:413-418	NULL
.	NULL

Brockhaus	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
J.	NULL
Schoenfeld	NULL
,	NULL
E.	NULL
J.	NULL
Schlaeger	NULL
,	NULL
W.	NULL
Hunzicher	NULL
,	NULL
W.	NULL
Less-lauer	NULL
,	NULL
and	NULL
H.	NULL
Loetsher	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
of	NULL
two	NULL
types	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptors	NULL
on	NULL
human	NULL
cell	NULL
lines	NULL
by	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:3127-3131	NULL
.	NULL

Budd	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
and	NULL
P.	NULL
F.	NULL
Mixter	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
origin	NULL
of	NULL
CD4-CD8-TCRafB	NULL
$	NULL
+	NULL
thymocytes	NULL
:	NULL
a	NULL
model	NULL
based	NULL
on	NULL
T-cell	NULL
receptor	NULL
avidity	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
16:428-431	NULL
.	NULL

Chéne	NULL
,	NULL
L.	NULL
,	NULL
M.	NULL
T.	NULL
Nugeyre	NULL
,	NULL
F.	NULL
Barré-Sinoussi	NULL
,	NULL
and	NULL
N.	NULL
Israél	NULL
.	NULL

1999	NULL
.	NULL

High-level	NULL
replication	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
thymocytes	NULL
requires	NULL
NF-kB	NULL
activation	NULL
through	NULL
interaction	NULL
with	NULL
thymic	NULL
epithelial	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

73:2064-2073	NULL
.	NULL

Coffin	NULL
,	NULL
J.	NULL
M.	NULL
1995	NULL
.	NULL

HIV	NULL
population	NULL
dynamics	NULL
in	NULL
vivo	NULL
:	NULL
implications	NULL
for	NULL
genetic	NULL
variation	NULL
,	NULL
pathogenesis	NULL
,	NULL
and	NULL
therapy	NULL
.	NULL

Science	NULL
267:483-489	NULL
.	NULL

De	NULL
Rossi	NULL
,	NULL
A.	NULL
,	NULL
M.-L.	NULL
Calabro	NULL
,	NULL
M.	NULL
Panozzo	NULL
,	NULL
D.	NULL
Bernardi	NULL
,	NULL
B.	NULL
Caruzo	NULL
,	NULL
G.	NULL
Tri-dente	NULL
,	NULL
and	NULL
L.	NULL
Chieco-Banchi	NULL
.	NULL

1990	NULL
.	NULL

In	NULL
vitro	NULL
studies	NULL
of	NULL
HIV-1	NULL
infection	NULL
in	NULL
thymic	NULL
lymphocytes	NULL
:	NULL
a	NULL
putative	NULL
role	NULL
of	NULL
the	NULL
thymus	NULL
in	NULL
AIDS	NULL
pathogenesis	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
6:287-297	NULL
.	NULL

Douek	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
R.	NULL
D.	NULL
McFarland	NULL
,	NULL
P.	NULL
H.	NULL
Keiser	NULL
,	NULL
E.	NULL
A.	NULL
Gage	NULL
,	NULL
J.	NULL
M.	NULL
Massey	NULL
,	NULL
B.	NULL
F.	NULL
Haynes	NULL
,	NULL
M.	NULL
A.	NULL
Polis	NULL
,	NULL
A.	NULL
T.	NULL
Haase	NULL
,	NULL
M.	NULL
B.	NULL
Feinberg	NULL
,	NULL
J.	NULL
L.	NULL
Sullivan	NULL
,	NULL
B.	NULL
D.	NULL
Jamieson	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Zack	NULL
,	NULL
L.	NULL
J.	NULL
Picker	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Koup	NULL
.	NULL

1998	NULL
.	NULL

Changes	NULL
in	NULL
thymic	NULL
function	NULL
with	NULL
age	NULL
and	NULL
during	NULL
the	NULL
treatment	NULL
of	NULL
HIV	NULL
infection	NULL
.	NULL

Nature	NULL
396	NULL
:	NULL
690-695	NULL
.	NULL

Galy	NULL
,	NULL
A.	NULL
,	NULL
S.	NULL
Verma	NULL
,	NULL
A.	NULL
Barcena	NULL
,	NULL
and	NULL
H.	NULL
Spits	NULL
.	NULL

1993	NULL
.	NULL

Precursors	NULL
of	NULL
CD3+CD4+CD8+	NULL
cells	NULL
in	NULL
the	NULL
human	NULL
thymus	NULL
are	NULL
defined	NULL
by	NULL
expression	NULL
of	NULL
CD34	NULL
.	NULL

Delineation	NULL
of	NULL
early	NULL
events	NULL
in	NULL
human	NULL
thymic	NULL
development	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:391-401	NULL
.	NULL

Hansen	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
L.	NULL
Guerrini	NULL
,	NULL
and	NULL
F.	NULL
Blasi	NULL
.	NULL

1994	NULL
.	NULL

Differential	NULL
DNA	NULL
sequence	NULL
specificity	NULL
and	NULL
regulation	NULL
of	NULL
HIV-1	NULL
enhancer	NULL
activity	NULL
by	NULL
crel-relA	NULL
transcription	NULL
factor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:22230-22237	NULL
.	NULL

Hays	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
C.	NULL
H.	NULL
Uittenbogaart	NULL
,	NULL
J.	NULL
C.	NULL
Brewer	NULL
,	NULL
L.	NULL
W.	NULL
Vollger	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Zack	NULL
.	NULL

1992	NULL
.	NULL

In	NULL
vitro	NULL
studies	NULL
of	NULL
HIV-1	NULL
expression	NULL
in	NULL
thymocytes	NULL
from	NULL
infants	NULL
and	NULL
children	NULL
.	NULL

AIDS	NULL
6:265-272	NULL
.	NULL

Herbelin	NULL
,	NULL
A.	NULL
,	NULL
F.	NULL
Machavoine	NULL
,	NULL
A.	NULL
Vicari	NULL
,	NULL
E.	NULL
Schneider	NULL
,	NULL
M.	NULL
Papiernik	NULL
,	NULL
H.	NULL
Ziltener	NULL
,	NULL
C.	NULL
Penit	NULL
,	NULL
and	NULL
M.	NULL
Dy	NULL
.	NULL

1994	NULL
.	NULL

Endogenous	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
is	NULL
involved	NULL
in	NULL
IL-1-	NULL
and	NULL
IL-7-induced	NULL
murine	NULL
thymocyte	NULL
proliferation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:1973-1981	NULL
.	NULL

Hernandez-Caselles	NULL
,	NULL
T.	NULL
,	NULL
M.	NULL
Martinez-Esparza	NULL
,	NULL
D.	NULL
Sancho	NULL
,	NULL
G.	NULL
Rubio	NULL
,	NULL
and	NULL
P.	NULL
Aparicio	NULL
.	NULL

1995	NULL
.	NULL

Interleukin-7	NULL
rescues	NULL
human	NULL
activated	NULL
T	NULL
lymphocytes	NULL
from	NULL
apoptosis	NULL
induced	NULL
by	NULL
glucocorticosteroids	NULL
and	NULL
regulates	NULL
Bel-2	NULL
and	NULL
CD25	NULL
expression	NULL
.	NULL

Hum	NULL
.	NULL

Immunol	NULL
.	NULL

43:181-189	NULL
.	NULL

Ho	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
A.	NULL
U.	NULL
Neumann	NULL
,	NULL
A.	NULL
S.	NULL
Perelson	NULL
,	NULL
W.	NULL
Chen	NULL
,	NULL
J.	NULL
M.	NULL
Leonard	NULL
,	NULL
and	NULL
M.	NULL
Markowitz	NULL
.	NULL

1995	NULL
.	NULL

Rapid	NULL
turnover	NULL
of	NULL
plasma	NULL
virions	NULL
and	NULL
CD4	NULL
lymphocytes	NULL
in	NULL
HIV-1	NULL
infection	NULL
.	NULL

Nature	NULL
373:123-126	NULL
.	NULL

Israel	NULL
,	NULL
N.	NULL
,	NULL
U.	NULL
Hazan	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
A.	NULL
Munier	NULL
,	NULL
S.	NULL
F.	NULL
Arenzana	NULL
,	NULL
F.	NULL
Bachelerie	NULL
,	NULL
A.	NULL
Israel	NULL
,	NULL
and	NULL
J.	NULL
L	NULL
Virelizier	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
stimulates	NULL
transcription	NULL
of	NULL
HIV-1	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
,	NULL
independently	NULL
and	NULL
synergistically	NULL
with	NULL
mitogens	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:3956-3960	NULL
.	NULL

Iversen	NULL
,	NULL
P.	NULL
O.	NULL
,	NULL
L.	NULL
B	NULL
.	NULL

To	NULL
,	NULL
and	NULL
A.	NULL
F.	NULL
Lopez	NULL
.	NULL

1996	NULL
.	NULL

Apoptosis	NULL
of	NULL
hemopoictic	NULL
cells	NULL
by	NULL
the	NULL
human	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
mutant	NULL
E21R	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:2785-2789	NULL
.	NULL

Jamieson	NULL
,	NULL
B.	NULL
D.	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Zack	NULL
.	NULL

1998	NULL
.	NULL

In	NULL
vivo	NULL
pathogenesis	NULL
of	NULL
a	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
reporter	NULL
virus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

72:6520-6526	NULL
.	NULL

Joshi	NULL
,	NULL
V.	NULL
V.	NULL
,	NULL
J.	NULL
M.	NULL
Oleske	NULL
,	NULL
S.	NULL
Saad	NULL
,	NULL
C.	NULL
Gadol	NULL
,	NULL
E.	NULL
Connor	NULL
,	NULL
R.	NULL
Bobila	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Minnefor	NULL
.	NULL

1986	NULL
.	NULL

Thymus	NULL
biopsy	NULL
in	NULL
children	NULL
with	NULL
acquired	NULL
immunodeficiency	NULL
syndrome	NULL
.	NULL

Arch	NULL
.	NULL

Pathol	NULL
.	NULL

Lab	NULL
.	NULL

Med	NULL
.	NULL

110:837-842	NULL
.	NULL

Jung	NULL
,	NULL
L.	NULL
K.	NULL
L.	NULL
,	NULL
B.	NULL
F.	NULL
Haynes	NULL
,	NULL
S.	NULL
Nakamura	NULL
,	NULL
S.	NULL
Pahwa	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Fu	NULL
.	NULL

1990	NULL
.	NULL

Expression	NULL
of	NULL
early	NULL
activation	NULL
antigen	NULL
(	NULL
CD69	NULL
)	NULL
during	NULL
human	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

141:466-472	NULL
.	NULL

Kinoshita	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Yokoda	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
A.	NULL
Miyajima	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
Bcl-2	NULL
expression	NULL
by	NULL
oncogenic	NULL
Ras	NULL
protein	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Oncogene	NULL
10:2207-2212	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

HIV	NULL
REPLICATION	NULL
IN	NULL
CD4+*	NULL
THYMOCYTES	NULL
-	NULL
7541	NULL
Kitchen	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
C.	NULL
H.	NULL
Uittenbogaart	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Zack	NULL
.	NULL

1997	NULL
.	NULL

Mechanism	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
localization	NULL
in	NULL
CD4-negative	NULL
thymo-cytes-differentiation	NULL
from	NULL
a	NULL
CD4-positive	NULL
precursor	NULL
allows	NULL
productive	NULL
infection	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:5713-5722	NULL
.	NULL

Kitchen	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Zack	NULL
.	NULL

1997	NULL
.	NULL

CXCR4	NULL
expression	NULL
during	NULL
lymphopoi-esis	NULL
:	NULL
implications	NULL
for	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infection	NULL
of	NULL
the	NULL
thymus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:6928-6934	NULL
.	NULL

Kopp	NULL
,	NULL
E.	NULL
B.	NULL
,	NULL
and	NULL
S.	NULL
Ghosh	NULL
.	NULL

1995	NULL
.	NULL

NF-kappa	NULL
B	NULL
and	NULL
rel	NULL
proteins	NULL
in	NULL
innate	NULL
immunity	NULL
.	NULL

Adv	NULL
.	NULL

Immunol	NULL
.	NULL

58:1-27	NULL
.	NULL

Kraft	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
I.	NULL
L.	NULL
Weissman	NULL
,	NULL
and	NULL
E.	NULL
K.	NULL
Waller	NULL
.	NULL

1993	NULL
.	NULL

Differentiation	NULL
of	NULL
CD3	NULL
4~8~	NULL
human	NULL
fetal	NULL
thymocytes	NULL
in	NULL
vivo	NULL
:	NULL
characterization	NULL
of	NULL
a	NULL
CD3~4*8~	NULL
intermediate	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:265-277	NULL
.	NULL

Marquez	NULL
,	NULL
C.	NULL
,	NULL
C.	NULL
Trigueros	NULL
,	NULL
E.	NULL
Fernandez	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Toribio	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
development	NULL
of	NULL
T	NULL
and	NULL
non-T	NULL
cell	NULL
lineages	NULL
from	NULL
CD34*	NULL
human	NULL
thymic	NULL
precursors	NULL
can	NULL
be	NULL
traced	NULL
by	NULL
the	NULL
differential	NULL
expression	NULL
of	NULL
CD44	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:475-483	NULL
.	NULL

May	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
S.	NULL
Ghosh	NULL
.	NULL

1997	NULL
.	NULL

Rel/NF-kappa	NULL
B	NULL
and	NULL
I	NULL
kappa	NULL
B	NULL
proteins	NULL
:	NULL
an	NULL
overview	NULL
.	NULL

Semin	NULL
.	NULL

Cancer	NULL
Biol	NULL
.	NULL

8:63-73	NULL
.	NULL

McCune	NULL
,	NULL
J.	NULL
M.	NULL
1997	NULL
.	NULL

Thymic	NULL
function	NULL
in	NULL
HIV-1	NULL
disease	NULL
.	NULL

Semin	NULL
.	NULL

Immunol	NULL
.	NULL

9:397-404	NULL
.	NULL

McCune	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
R.	NULL
Loftus	NULL
,	NULL
D.	NULL
K.	NULL
Schmidt	NULL
,	NULL
P.	NULL
Carroll	NULL
,	NULL
D.	NULL
Webster	NULL
,	NULL
Y.	NULL
L.	NULL
Swor	NULL
,	NULL
I.	NULL
R.	NULL
Francis	NULL
,	NULL
B.	NULL
H.	NULL
Gross	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Grant	NULL
.	NULL

1998	NULL
.	NULL

High	NULL
prevalence	NULL
of	NULL
thymic	NULL
tissue	NULL
in	NULL
adults	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus-1	NULL
infection	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Investig	NULL
.	NULL

101:2301-2308	NULL
.	NULL

Moretta	NULL
,	NULL
L.	NULL
,	NULL
E.	NULL
Ciccone	NULL
,	NULL
S.	NULL
Ferrini	NULL
,	NULL
P.	NULL
G.	NULL
Pelicci	NULL
,	NULL
M.	NULL
C.	NULL
Mingari	NULL
,	NULL
J.	NULL
Zeromski	NULL
,	NULL
C.	NULL
Bottino	NULL
,	NULL
C.	NULL
Grossi	NULL
,	NULL
and	NULL
A.	NULL
Moretta	NULL
.	NULL

1991	NULL
.	NULL

Molecular	NULL
and	NULL
cellular	NULL
analysis	NULL
of	NULL
human	NULL
T	NULL
lymphocytes	NULL
expressing	NULL
gamma	NULL
delta	NULL
T-cell	NULL
receptor	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

120:117-125	NULL
.	NULL

Muller	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
V.	NULL
Krenn	NULL
,	NULL
C.	NULL
Schindler	NULL
,	NULL
S.	NULL
Czub	NULL
,	NULL
C.	NULL
Stahl-Hennig	NULL
,	NULL
C.	NULL
Couli-baly	NULL
,	NULL
G.	NULL
Hunsmann	NULL
,	NULL
C.	NULL
Kneitz	NULL
,	NULL
T.	NULL
Kerbau	NULL
,	NULL
A.	NULL
Rethwilm	NULL
,	NULL
V.	NULL
terMeulen	NULL
,	NULL
and	NULL
H.	NULL
K.	NULL
Miiller-Hermelink	NULL
.	NULL

1993	NULL
.	NULL

Alteration	NULL
of	NULL
thymus	NULL
cortical	NULL
epithelium	NULL
and	NULL
interdigitating	NULL
dendritic	NULL
cells	NULL
but	NULL
no	NULL
increase	NULL
of	NULL
thymocyte	NULL
cell	NULL
death	NULL
in	NULL
the	NULL
early	NULL
course	NULL
of	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
infection	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

143:699-713	NULL
.	NULL

Pakker	NULL
,	NULL
N.	NULL
G.	NULL
,	NULL
D.	NULL
W.	NULL
Notermans	NULL
,	NULL
R.	NULL
de	NULL
Boer	NULL
,	NULL
M.	NULL
T.	NULL
Roos	NULL
,	NULL
F.	NULL
de	NULL
Wolf	NULL
,	NULL
A.	NULL
Hill	NULL
,	NULL
J.	NULL
M.	NULL
Leonard	NULL
,	NULL
S.	NULL
A.	NULL
Danner	NULL
,	NULL
F.	NULL
Miedema	NULL
,	NULL
and	NULL
P.	NULL
T.	NULL
Schellekens	NULL
.	NULL

1998	NULL
.	NULL

Biphasic	NULL
kinetics	NULL
of	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
after	NULL
triple	NULL
combination	NULL
therapy	NULL
in	NULL
HIV-1	NULL
infection	NULL
:	NULL
a	NULL
composite	NULL
of	NULL
redistribution	NULL
and	NULL
proliferation	NULL
.	NULL

Nat	NULL
.	NULL

Med	NULL
.	NULL

4:208-214	NULL
.	NULL

Papiernik	NULL
,	NULL
M.	NULL
,	NULL
Y.	NULL
Brossard	NULL
,	NULL
N.	NULL
Mulliez	NULL
,	NULL
J.	NULL
Roume	NULL
,	NULL
C.	NULL
Brechot	NULL
,	NULL
F.	NULL
Barin	NULL
,	NULL
A.	NULL
Goudeau	NULL
,	NULL
J.-F.	NULL
Bach	NULL
,	NULL
C.	NULL
Griscelli	NULL
,	NULL
R.	NULL
Henrion	NULL
,	NULL
and	NULL
R.	NULL
Vazeux	NULL
.	NULL

1992	NULL
.	NULL

Thymic	NULL
abnormalities	NULL
in	NULL
fetuses	NULL
aborted	NULL
from	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
seropositive	NULL
women	NULL
.	NULL

Pediatrics	NULL
89:297-301.	NULL
.	NULL

Pedroza-Martins	NULL
,	NULL
L.	NULL
,	NULL
K.	NULL
B.	NULL
Gurney	NULL
,	NULL
B.	NULL
E.	NULL
Torbett	NULL
,	NULL
and	NULL
C.	NULL
Uittenbogaart	NULL
.	NULL

1998	NULL
.	NULL

Differential	NULL
tropism	NULL
and	NULL
replication	NULL
kinetics	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
isolates	NULL
in	NULL
thymocytes	NULL
:	NULL
coreceptor	NULL
expression	NULL
allows	NULL
viral	NULL
entry	NULL
,	NULL
but	NULL
productive	NULL
infection	NULL
of	NULL
distinct	NULL
subsets	NULL
is	NULL
determined	NULL
at	NULL
the	NULL
postentry	NULL
level	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

72:9441-9452	NULL
.	NULL

Pope	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Gezelter	NULL
,	NULL
N.	NULL
Gallo	NULL
,	NULL
L.	NULL
Hoffman	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Steinman	NULL
.	NULL

1995	NULL
.	NULL

Low	NULL
levels	NULL
of	NULL
HIV-1	NULL
infection	NULL
in	NULL
cutaneous	NULL
dendritic	NULL
cells	NULL
promote	NULL
extensive	NULL
viral	NULL
replication	NULL
upon	NULL
binding	NULL
to	NULL
memory	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182:2045-2056	NULL
.	NULL

Rosenzweig	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
P.	NULL
Clark	NULL
,	NULL
and	NULL
G.	NULL
N.	NULL
Gaulton	NULL
.	NULL

1993	NULL
.	NULL

Selective	NULL
thymocyte	NULL
depletion	NULL
in	NULL
neonatal	NULL
HIV-1	NULL
thymic	NULL
infection	NULL
.	NULL

AIDS	NULL
7:1601-1605	NULL
.	NULL

Rothe	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
Chéne	NULL
,	NULL
M.	NULL
Nugeyre	NULL
,	NULL
F.	NULL
Barré-Sinoussi	NULL
,	NULL
and	NULL
N.	NULL
Israél	NULL
.	NULL

1998	NULL
.	NULL

Contact	NULL
with	NULL
thymic	NULL
epithelial	NULL
cells	NULL
as	NULL
a	NULL
prerequisite	NULL
for	NULL
cytokines	NULL
enhanced	NULL
HIV-1	NULL
replication	NULL
in	NULL
thymocytes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

72:5852-5861	NULL
.	NULL

Ryffel	NULL
,	NULL
B.	NULL
,	NULL
M.	NULL
Brockhaus	NULL
,	NULL
B.	NULL
Greiner	NULL
,	NULL
M.	NULL
J.	NULL
Mihatsh	NULL
,	NULL
and	NULL
F.	NULL
Gudat	NULL
.	NULL

1991	NULL
.	NULL

Tumour	NULL
necrosis	NULL
factor	NULL
receptor	NULL
distribution	NULL
in	NULL
human	NULL
lymphoid	NULL
tissue	NULL
.	NULL

Immunology	NULL
74:446-452	NULL
.	NULL

Sonenshein	NULL
,	NULL
G.	NULL
E.	NULL
1997	NULL
.	NULL

Rel/NF-kappa	NULL
B	NULL
transcription	NULL
factors	NULL
and	NULL
the	NULL
control	NULL
of	NULL
apoptosis	NULL
.	NULL

Semin	NULL
.	NULL

Cancer	NULL
Biol	NULL
.	NULL

2:113-119	NULL
.	NULL

Stanley	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
J.	NULL
M.	NULL
McCune	NULL
,	NULL
H.	NULL
Kaneshima	NULL
,	NULL
J.	NULL
S.	NULL
Justement	NULL
,	NULL
M.	NULL
Sullivan	NULL
,	NULL
E.	NULL
Boone	NULL
,	NULL
M.	NULL
Baseler	NULL
,	NULL
J.	NULL
Adelsberger	NULL
,	NULL
M.	NULL
Bonyhadi	NULL
,	NULL
J.	NULL
Orenstein	NULL
,	NULL
C.	NULL
H.	NULL
Fox	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1993	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
infection	NULL
of	NULL
the	NULL
human	NULL
thymus	NULL
and	NULL
disruption	NULL
of	NULL
the	NULL
thymic	NULL
microenvironment	NULL
in	NULL
the	NULL
SCID-hu	NULL
mouse	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1151-1163	NULL
.	NULL

Su	NULL
,	NULL
L.	NULL
,	NULL
H.	NULL
Kaneshima	NULL
,	NULL
M.	NULL
Bonybadi	NULL
,	NULL
S.	NULL
Salimi	NULL
,	NULL
D.	NULL
Kraft	NULL
,	NULL
L.	NULL
Rabin	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
McCune	NULL
.	NULL

1995	NULL
.	NULL

HIV-1-induced	NULL
thymocyte	NULL
depletion	NULL
is	NULL
associated	NULL
with	NULL
indirect	NULL
cytopathogenicity	NULL
and	NULL
infection	NULL
of	NULL
progenitor	NULL
cells	NULL
in	NULL
vivo	NULL
.	NULL

Immunity	NULL
2125-36	NULL
.	NULL

Suda	NULL
,	NULL
T.	NULL
,	NULL
R.	NULL
Murray	NULL
,	NULL
C.	NULL
Guidos	NULL
,	NULL
and	NULL
A.	NULL
Zlotnik	NULL
.	NULL

1990	NULL
.	NULL

Growth-promoting	NULL
activity	NULL
of	NULL
IL-1	NULL
alpha	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor-alpha	NULL
in	NULL
combination	NULL
with	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
or	NULL
IL-7	NULL
on	NULL
murine	NULL
thymocytes	NULL
.	NULL

Differential	NULL
effects	NULL
on	NULL
CD4/	NULL
CD8	NULL
subsets	NULL
and	NULL
on	NULL
CD3+/CD3-	NULL
double-negative	NULL
thymocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:3039-3045	NULL
.	NULL

Sudo	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Nishikawa	NULL
,	NULL
N.	NULL
Ohno	NULL
,	NULL
N.	NULL
Akiyama	NULL
,	NULL
M.	NULL
Tamakoshi	NULL
,	NULL
H.	NULL
Yoshida	NULL
,	NULL
and	NULL
S.	NULL
Nishikawa	NULL
.	NULL

1993	NULL
.	NULL

Expression	NULL
and	NULL
function	NULL
of	NULL
the	NULL
interleukin	NULL
7	NULL
receptor	NULL
in	NULL
murine	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:9125-9129.	NULL
.	NULL

Tanaka	NULL
,	NULL
K.	NULL
E.	NULL
,	NULL
W.	NULL
C.	NULL
Hatch	NULL
,	NULL
Y.	NULL
Kress	NULL
,	NULL
R.	NULL
Sociro	NULL
,	NULL
T.	NULL
Calvelli	NULL
,	NULL
W.	NULL
K.	NULL
Rash	NULL
baum	NULL
,	NULL
A.	NULL
Rubinstein	NULL
,	NULL
and	NULL
W.	NULL
D.	NULL
Lyman	NULL
.	NULL

1992	NULL
.	NULL

HIV-1	NULL
infection	NULL
of	NULL
human	NULL
fetal	NULL
thymocytes	NULL
.	NULL

J	NULL
.	NULL

Acquired	NULL
Immune	NULL
Defic	NULL
.	NULL

Syndr	NULL
.	NULL

5:94-101	NULL
.	NULL

7542	NULL
53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

CHENE	NULL
ET	NULL
AL	NULL
.	NULL

Tartaglia	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
D.	NULL
V.	NULL
Goeddel	NULL
,	NULL
C.	NULL
Reynolds	NULL
,	NULL
I.	NULL
S.	NULL
Figari	NULL
,	NULL
R.	NULL
F.	NULL
Weber	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Palladino	NULL
.	NULL

1993	NULL
.	NULL

Stimulation	NULL
of	NULL
human	NULL
T-cell	NULL
proliferation	NULL
by	NULL
specific	NULL
activation	NULL
of	NULL
the	NULL
75-kDa	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151	NULL
:	NULL
4637-4641	NULL
.	NULL

Terstappen	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Huang	NULL
,	NULL
and	NULL
L.	NULL
Picker	NULL
.	NULL

1992	NULL
.	NULL

Flow	NULL
cytometry	NULL
assessment	NULL
of	NULL
human	NULL
T-cell	NULL
differentiation	NULL
in	NULL
thymus	NULL
and	NULL
bone	NULL
marrow	NULL
.	NULL

Blood	NULL
79:666-677	NULL
.	NULL

Uittenbogaart	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
D.	NULL
J.	NULL
Anisman	NULL
,	NULL
B.	NULL
D.	NULL
Jamieson	NULL
,	NULL
S.	NULL
Kitchen	NULL
,	NULL
I.	NULL
Schmid	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Zack	NULL
,	NULL
and	NULL
E.	NULL
F.	NULL
Hays	NULL
.	NULL

1996	NULL
.	NULL

Differential	NULL
tropism	NULL
of	NULL
HIV-1	NULL
isolates	NULL
for	NULL
distinct	NULL
thymocyte	NULL
subsets	NULL
in	NULL
vitro	NULL
.	NULL

AIDS	NULL
10:9-16	NULL
.	NULL

Uittenbogaart	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
D.	NULL
J.	NULL
Anisman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Zack	NULL
,	NULL
A.	NULL
Economides	NULL
,	NULL
I.	NULL
Schmid	NULL
,	NULL
and	NULL
E.	NULL
F.	NULL
Hays	NULL
.	NULL

1995	NULL
.	NULL

Effects	NULL
of	NULL
cytokines	NULL
on	NULL
HIV-1	NULL
production	NULL
by	NULL
thymocytes	NULL
.	NULL

Thymus	NULL
23:155-175	NULL
.	NULL

Valentin	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
T.	NULL
Nugeyre	NULL
,	NULL
F.	NULL
Vuillier	NULL
,	NULL
L.	NULL
Boumsell	NULL
,	NULL
M.	NULL
Schmid	NULL
,	NULL
F.	NULL
Barré-Sinoussi	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Pereira	NULL
.	NULL

1994	NULL
.	NULL

Two	NULL
subpopulations	NULL
of	NULL
human	NULL
triple-negative	NULL
thymic	NULL
cells	NULL
are	NULL
susceptible	NULL
to	NULL
infection	NULL
by	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:3041-3050	NULL
.	NULL

Vanhecke	NULL
,	NULL
D.	NULL
,	NULL
G.	NULL
Leclercq	NULL
,	NULL
J	NULL
.	NULL

Plum	NULL
,	NULL
and	NULL
B.	NULL
Vandekerckhove	NULL
.	NULL

1995	NULL
.	NULL

Characterization	NULL
of	NULL
distinct	NULL
stages	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
human	NULL
CD69+CD3+	NULL
thymocytes	NULL
and	NULL
identification	NULL
of	NULL
thymic	NULL
emigrants	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:1862-1872	NULL
.	NULL

Wei	NULL
,	NULL
X.	NULL
,	NULL
S.	NULL
K.	NULL
Ghosh	NULL
,	NULL
M.	NULL
E.	NULL
Taylor	NULL
,	NULL
V.	NULL
A.	NULL
Johnson	NULL
,	NULL
E.	NULL
A.	NULL
Emini	NULL
,	NULL
P.	NULL
Deutsch	NULL
,	NULL
J.	NULL
D.	NULL
Lifson	NULL
,	NULL
S.	NULL
Bonhoefer	NULL
,	NULL
M.	NULL
A.	NULL
Nowak	NULL
,	NULL
B.	NULL
H.	NULL
Hahn	NULL
,	NULL
M.	NULL
S.	NULL
Saag	NULL
,	NULL
and	NULL
G.	NULL
M.	NULL
Shaw	NULL
.	NULL

1995	NULL
.	NULL

Viral	NULL
dynamics	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infection	NULL
.	NULL

Nature	NULL
373:117-122	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

J.	NULL
Virou	NULL
.	NULL

Whiteside	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1997	NULL
.	NULL

I	NULL
kappa	NULL
B	NULL
proteins	NULL
:	NULL
structure	NULL
,	NULL
function	NULL
and	NULL
regulation	NULL
.	NULL

Semin	NULL
.	NULL

Cancer	NULL
Biol	NULL
.	NULL

8:75-82	NULL
.	NULL

Withers-Ward	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
R.	NULL
G.	NULL
Amado	NULL
,	NULL
P.	NULL
S.	NULL
Koka	NULL
,	NULL
B.	NULL
D.	NULL
Jamieson	NULL
,	NULL
A.	NULL
H.	NULL
Kaplan	NULL
,	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Zack	NULL
.	NULL

1997	NULL
.	NULL

Transient	NULL
renewal	NULL
of	NULL
thymopoiesis	NULL
in	NULL
HIV-infected	NULL
human	NULL
thymic	NULL
implants	NULL
following	NULL
antiviral	NULL
therapy	NULL
.	NULL

Nat	NULL
.	NULL

Med	NULL
.	NULL

3:1102-1109	NULL
.	NULL

Woo	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
G.	NULL
A	NULL
.	NULL

Dean	NULL
,	NULL
N.	NULL
C.	NULL
Pedersen	NULL
,	NULL
and	NULL
P.	NULL
F.	NULL
Moore	NULL
.	NULL

1997	NULL
.	NULL

Immuno-pathologic	NULL
changes	NULL
in	NULL
the	NULL
thymus	NULL
during	NULL
the	NULL
acute	NULL
stage	NULL
of	NULL
experimentally	NULL
induced	NULL
immunodeficiency	NULL
virus	NULL
infection	NULL
in	NULL
juvenile	NULL
cats	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:8632-8641	NULL
.	NULL

Wykrzykowska	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
M.	NULL
Rosenzweig	NULL
,	NULL
R.	NULL
S.	NULL
Veazey	NULL
,	NULL
M.	NULL
A.	NULL
Simon	NULL
,	NULL
K.	NULL
Hal-vorsen	NULL
,	NULL
R.	NULL
C.	NULL
Desrosier	NULL
,	NULL
R.	NULL
P.	NULL
Johnson	NULL
,	NULL
and	NULL
A.	NULL
Lackner	NULL
.	NULL

1998	NULL
.	NULL

Early	NULL
regeneration	NULL
of	NULL
thymic	NULL
progenitors	NULL
in	NULL
thesus	NULL
macaques	NULL
infected	NULL
with	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187:1767-1778	NULL
.	NULL

Zaitseva	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
S.	NULL
Lee	NULL
,	NULL
R.	NULL
L.	NULL
Rabin	NULL
,	NULL
H.	NULL
L.	NULL
Tiffany	NULL
,	NULL
J.	NULL
M.	NULL
Farber	NULL
,	NULL
K.	NULL
W.	NULL
C.	NULL
Peden	NULL
,	NULL
P.	NULL
M.	NULL
Murphy	NULL
,	NULL
and	NULL
H.	NULL
Golding	NULL
.	NULL

1998	NULL
.	NULL

CXCR4	NULL
and	NULL
CCR5	NULL
on	NULL
human	NULL
thymocytes	NULL
:	NULL
biological	NULL
function	NULL
and	NULL
role	NULL
in	NULL
HIV-1	NULL
infection	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:3103-3113	NULL
.	NULL

Zhang	NULL
,	NULL
Z.	NULL
Q.	NULL
,	NULL
D.	NULL
W.	NULL
Notermans	NULL
,	NULL
G.	NULL
Sedgewick	NULL
,	NULL
W.	NULL
Cavert	NULL
,	NULL
S.	NULL
Wictgrefe	NULL
,	NULL
M.	NULL
Zupancic	NULL
,	NULL
K.	NULL
Gebhard	NULL
,	NULL
K.	NULL
Henry	NULL
,	NULL
L.	NULL
Boies	NULL
,	NULL
Z.	NULL
Chen	NULL
,	NULL
M.	NULL
Jenkins	NULL
,	NULL
R.	NULL
Mills	NULL
,	NULL
H.	NULL
McDade	NULL
,	NULL
C.	NULL
Goodwin	NULL
,	NULL
C.	NULL
M.	NULL
Schuwirth	NULL
,	NULL
S.	NULL
A.	NULL
Danner	NULL
,	NULL
and	NULL
A.	NULL
T.	NULL
Haase	NULL
.	NULL

1998	NULL
.	NULL

Kinetics	NULL
of	NULL
CD4+	NULL
T	NULL
cell	NULL
repopulation	NULL
of	NULL
lymphoid	NULL
tissues	NULL
after	NULL
treatment	NULL
of	NULL
HIV	NULL
infection	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95:1154-1159	NULL
.	NULL

